data_1se9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1se9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 HD12 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HD13 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.466 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.462 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HD3' ' OH ' ' A' ' 74' ' ' TYR . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 70' ' ' THR . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.434 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 8.2 pt20 . . . . . 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.618 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' N ' ' HD2' ' A' ' 23' ' ' LYS . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.726 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' HG11 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.459 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 . . . . . 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.443 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 HG22 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 . . . . . 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.409 ' N ' HD11 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.478 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.402 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 HD13 HD11 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.46 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 50.7 mt-30 . . . . . 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.682 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 49' ' ' GLY . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CD1' HD11 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' HE3' ' A' ' 88' ' ' MET . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.475 ' HE3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.551 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 25.8 mp0 . . . . . 0 N--CA 1.41 -2.432 0 CA-C-O 121.461 0.648 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.638 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' HG11 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.587 HG11 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 . . . . . 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.479 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.501 ' OE1' ' HD3' ' A' ' 26' ' ' PRO . 7.2 pt20 . . . . . 0 N--CA 1.438 -1.026 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.702 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 HD13 HD12 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.702 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 39' ' ' ILE . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 29' ' ' THR . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.66 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.613 ' O ' HG13 ' A' ' 39' ' ' ILE . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' ILE . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD ' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 52' ' ' THR . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.431 ' OG ' HD13 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 . . . . . 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD23 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.642 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 58' ' ' LEU . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 . . . . . 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.242 0.673 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.453 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.511 ' OG ' HD13 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.516 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.496 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 . . . . . 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t . . . . . 0 N--CA 1.437 -1.075 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.723 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.633 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.633 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.49 ' N ' HD21 ' A' ' 67' ' ' ASN . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 . . . . . 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.46 ' SD ' HD12 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.657 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 34' ' ' LEU . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.44 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.56 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.436 ' HE3' HG23 ' A' ' 10' ' ' ILE . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 79.0 mt-30 . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.651 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 39' ' ' ILE . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG12 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.404 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.697 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 HD12 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.697 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.496 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.413 HD12 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.637 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.572 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m120 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.493 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' H ' HD21 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 . . . . . 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.69 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.407 ' HB3' HG23 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.69 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.419 HG21 ' HZ1' ' A' ' 23' ' ' LYS . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 49' ' ' GLY . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.6 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.585 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 60.3 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.423 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 14' ' ' LEU . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.406 HD13 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.617 ' O ' HG21 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' CG ' HG21 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' O ' HG21 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.5 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 . . . . . 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.403 HG21 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 . . . . . 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 34' ' ' LEU . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.693 HD13 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 . . . . . 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.693 ' SD ' HD13 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.627 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.545 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.636 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' HG21 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 35' ' ' LYS . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.511 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 48' ' ' ASN . 0.8 OUTLIER 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' OE1' ' HB2' ' A' ' 51' ' ' LYS . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' C ' HD13 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.414 HD13 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.465 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' HE2' ' A' ' 88' ' ' MET . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.509 -0.613 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.63 147.57 25.85 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -71.65 134.65 46.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.366 7.2 p 49.68 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 125.393 1.477 . . . . 0.0 113.796 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.266 7.4 p-80 -76.45 81.16 3.17 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.164 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -115.44 85.56 2.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.282 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 -109.97 -168.74 1.36 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 HD12 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HD13 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.466 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.462 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HD3' ' OH ' ' A' ' 74' ' ' TYR . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 70' ' ' THR . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 -90.62 175.44 7.04 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 m -86.43 159.48 53.0 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.94 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.93 -177.63 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.38 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 80' ' ' ASN . 37.9 t -74.2 -1.54 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.287 1.041 . . . . 0.0 110.71 -177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 p -83.52 21.57 1.18 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.33 1.062 . . . . 0.0 110.959 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 78' ' ' VAL . 7.6 t30 -133.34 141.54 47.98 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.36 -178.62 6.22 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.08 21.2 2.83 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.345 0.593 . . . . 0.0 111.22 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.22 -6.23 55.64 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.054 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.23 115.84 24.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.07 146.08 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.16 129.94 30.96 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.74 153.85 43.43 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.71 2.274 . . . . 0.0 112.507 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.9 102.66 5.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m 57.07 84.86 0.09 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.81 139.59 4.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -174.0 109.56 0.15 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 123.774 0.671 . . . . 0.0 110.866 -175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' HG3' ' HE2' ' A' ' 101' ' ' LYS . 13.9 tp10 38.64 -94.1 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.821 1.249 . . . . 0.0 112.46 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.419 ' HE2' ' HG3' ' A' ' 100' ' ' GLU 0.363 0.0 OUTLIER . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.244 0.618 . . . . 0.0 111.199 166.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.43 170.87 2.47 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.61 82.79 6.54 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.23 121.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 122.164 0.983 . . . . 0.0 110.811 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.55 -52.16 0.75 Allowed 'General case' 0 C--N 1.263 -3.163 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.33 95.81 2.6 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.88 0.848 . . . . 0.0 111.045 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.434 ' HG3' ' HB3' ' A' ' 24' ' ' ALA . 8.2 pt20 -148.42 156.12 42.08 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.618 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' N ' ' HD2' ' A' ' 23' ' ' LYS . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.618 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.726 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.617 ' O ' HG11 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.459 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -96.59 173.51 7.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.6 m -114.04 131.49 23.15 Favored Pre-proline 0 N--CA 1.408 -2.557 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.13 122.62 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.224 1.95 . . . . 0.0 110.884 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.58 -10.2 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.744 0.783 . . . . 0.0 110.404 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 t 62.9 32.69 15.59 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.135 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -148.81 147.89 29.29 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.43 -177.91 5.74 Favored 'General case' 0 N--CA 1.393 -3.284 0 C-N-CA 123.749 0.82 . . . . 0.0 109.58 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.99 113.39 4.62 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.07 46.91 3.68 Favored Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.323 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.78 154.46 26.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -85.86 130.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.29 132.12 82.3 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.06 160.63 21.69 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.372 2.048 . . . . 0.0 110.106 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -48.88 115.36 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-O 121.915 0.865 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -86.25 70.57 10.54 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.847 0.832 . . . . 0.0 111.151 -173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 172.88 100.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 126.876 2.07 . . . . 0.0 105.496 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 6.1 ttpm? -80.62 90.84 5.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.13 164.46 26.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.058 -0.973 . . . . 0.0 109.705 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.311 178.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.5 105.13 4.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.271 11.0 pt-20 43.29 82.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.094 1.357 . . . . 0.0 114.15 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.93 129.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.981 0.896 . . . . 0.0 110.422 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -137.53 30.7 2.6 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.921 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -71.44 93.62 1.18 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.769 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.88 -160.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 172.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.443 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 HG22 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 -74.41 124.47 26.58 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -71.22 126.95 91.92 Favored Pre-proline 0 N--CA 1.42 -1.966 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.88 109.48 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.14 1.893 . . . . 0.0 110.675 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.5 p -116.78 -43.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -159.21 126.41 4.75 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -84.95 95.96 9.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.48 177.61 6.07 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.846 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 118.67 10.05 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 46.29 7.07 Favored Glycine 0 C--N 1.287 -2.14 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.88 148.74 33.02 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.156 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.23 135.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 117.2 61.09 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.12 175.39 11.2 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.716 2.277 . . . . 0.0 110.708 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.45 77.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.881 1.324 . . . . 0.0 112.156 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 p -141.11 124.55 16.68 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -150.01 174.23 12.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.674 0.273 . . . . 0.0 110.489 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.63 88.59 7.35 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 101' ' ' LYS . 5.1 pt-20 -100.63 -93.31 0.28 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.559 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 21.4 ptmt . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.684 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.24 0.578 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.82 39.65 26.78 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.153 0.977 . . . . 0.0 109.949 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.82 103.99 7.13 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.909 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 7' ' ' GLN . 26.2 t -121.27 140.33 45.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -85.93 11.36 11.6 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.142 0.972 . . . . 0.0 110.309 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -24.34 28.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 4' ' ' VAL . 2.3 mp0 -89.69 -178.29 5.49 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.823 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.409 ' N ' HD11 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' CG2' ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 32.0 mmt180 -85.55 -176.99 6.31 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.75 158.57 72.97 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.618 ' O ' HG12 ' A' ' 78' ' ' VAL . 4.2 Cg_exo -39.2 136.39 0.89 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 124.597 3.531 . . . . 0.0 113.757 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 77' ' ' PRO . 3.3 p 74.75 -3.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 128.669 2.788 . . . . 0.0 111.065 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 69.84 103.01 0.06 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 125.571 1.548 . . . . 0.0 112.092 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 21.5 p-10 -89.52 94.48 9.88 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.734 0.778 . . . . 0.0 109.902 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -81.98 169.99 16.11 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.27 132.6 2.5 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.77 85.8 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.81 154.41 39.19 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.358 0.663 . . . . 0.0 110.075 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t -84.66 133.37 29.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.567 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 HD13 HD11 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.42 140.84 27.0 Favored Pre-proline 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.414 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 36.4 Cg_exo -57.36 140.93 94.52 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 121.958 1.772 . . . . 0.0 110.296 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.74 -27.67 43.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.458 0.647 . . . . 0.0 111.553 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -143.36 100.68 3.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.613 0.72 . . . . 0.0 109.926 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 95' ' ' PRO . 9.2 tp10 -154.37 156.99 37.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -82.55 155.76 24.33 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -100.41 164.77 11.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? . . . . . 0 C--O 1.265 1.921 0 C-N-CA 124.772 1.229 . . . . 0.0 113.948 -176.572 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.242 0.681 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.5 172.89 13.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.832 0.349 . . . . 0.0 111.069 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.2 107.1 2.44 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.79 127.31 37.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -112.65 161.85 16.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -75.43 90.0 2.68 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.578 0.704 . . . . 0.0 110.629 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.46 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 50.7 mt-30 -91.73 160.1 15.51 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.682 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 49' ' ' GLY . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CD1' HD11 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 -64.8 142.01 58.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 m -91.85 126.55 53.21 Favored Pre-proline 0 N--CA 1.422 -1.864 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.91 -179.83 3.45 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.837 2.358 . . . . 0.0 113.861 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.354 8.4 p 49.29 89.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.5 m 51.89 29.63 6.25 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.627 -1.624 . . . . 0.0 114.827 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -97.0 -65.93 0.93 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -92.66 -178.92 5.01 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.603 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.57 91.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.309 1.044 . . . . 0.0 112.35 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 129.64 -47.9 1.0 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.9 155.03 19.05 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.533 -0.833 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.07 133.37 29.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' HE3' ' A' ' 88' ' ' MET . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.475 ' HE3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.551 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.63 129.83 26.82 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.54 141.66 97.66 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.148 1.899 . . . . 0.0 110.414 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.36 -40.68 89.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.058 0.456 . . . . 0.0 109.906 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.1 t -137.84 92.72 2.7 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.82 0.819 . . . . 0.0 112.132 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 99.11 0.77 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 66.83 99.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.731 1.212 . . . . 0.0 111.224 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 -2.04 19.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.348 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.406 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.44 140.26 48.35 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -43.07 108.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.628 1.205 . . . . 0.0 111.382 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.81 138.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.278 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -94.07 177.88 5.83 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.382 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.24 99.08 12.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 25.8 mp0 -94.46 156.24 16.56 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.535 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.638 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' HG11 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.587 HG11 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 -86.12 144.26 27.61 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.4 m -111.91 133.32 21.64 Favored Pre-proline 0 N--CA 1.399 -3.011 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.14 107.92 0.29 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.444 2.096 . . . . 0.0 114.268 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.39 -75.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.944 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.9 m -164.93 139.48 5.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 123.839 0.855 . . . . 0.0 110.174 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -118.05 95.04 4.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.423 0.63 . . . . 0.0 110.07 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.02 170.21 11.3 Favored 'General case' 0 N--CA 1.385 -3.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.251 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.97 91.97 5.29 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.02 24.83 3.46 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.017 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.21 115.85 16.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t -86.66 122.47 38.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.479 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.54 118.18 38.42 Favored Pre-proline 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.74 156.56 60.89 Favored 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 122.961 2.441 . . . . 0.0 113.557 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.78 95.95 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.2 m -68.12 108.98 3.33 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.198 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.84 129.7 20.53 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 68.29 98.95 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.421 1.076 . . . . 0.0 108.988 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.19 105.02 12.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.706 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.247 0.929 0 C-N-CA 124.583 1.153 . . . . 0.0 113.505 175.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 120.345 0.117 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.5 31.0 19.59 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.407 1.083 . . . . 0.0 111.411 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 169.07 9.49 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.568 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.0 t -78.61 105.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -125.25 133.44 52.69 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 179.4 -31.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.501 ' OE1' ' HD3' ' A' ' 26' ' ' PRO . 7.2 pt20 -75.45 -174.32 2.4 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.982 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.702 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 HD13 HD12 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.702 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 39' ' ' ILE . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 29' ' ' THR . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -105.38 110.57 22.97 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -103.13 123.77 40.72 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.69 139.11 2.19 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.152 1.901 . . . . 0.0 113.89 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.12 -28.86 16.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 122.415 1.103 . . . . 0.0 108.157 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.7 t -156.26 164.8 37.9 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.48 -57.64 11.86 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.38 0.536 . . . . 0.0 111.198 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -102.87 164.7 11.47 Favored 'General case' 1 N--CA 1.374 -4.248 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -179.17 129.32 0.1 Allowed 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.94 54.24 3.8 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.47 153.61 25.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.85 131.09 66.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.22 122.56 57.58 Favored Pre-proline 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.24 117.7 4.63 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 106.039 -2.331 . . . . 0.0 106.039 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.68 129.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -168.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -94.61 91.67 6.68 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.283 38.5 tt0 -67.09 94.15 0.33 Allowed 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -163.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 177.83 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.428 2.691 . . . . 0.0 104.94 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.12 -37.2 0.25 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.916 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.36 120.37 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.74 1.275 . . . . 0.0 111.595 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.14 113.86 5.02 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.523 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -92.66 -16.96 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 122.606 1.193 . . . . 0.0 109.377 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -113.94 140.01 48.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 113.71 -1.586 . . . . 0.0 106.809 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -91.19 167.39 12.37 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.731 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -116.68 177.53 4.67 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.561 1.144 . . . . 0.0 108.375 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.66 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.613 ' O ' HG13 ' A' ' 39' ' ' ILE . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' ILE . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD ' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 52' ' ' THR . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.431 ' OG ' HD13 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -99.18 151.72 20.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -90.4 166.02 21.23 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 168.14 2.4 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.76 2.307 . . . . 0.0 112.466 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.332 14.4 p 58.64 109.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.938 1.695 . . . . 0.0 112.941 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.8 m -62.91 111.0 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.765 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -95.45 128.74 42.55 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.106 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.24 168.28 18.6 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.465 0.65 . . . . 0.0 111.299 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.83 78.19 9.11 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.345 0.593 . . . . 0.0 111.784 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.58 -35.51 11.7 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.06 149.35 32.2 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t -86.59 130.18 37.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD23 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.02 154.33 60.61 Favored Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.28 130.06 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.47 80.63 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.706 0.765 . . . . 0.0 111.671 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -85.08 80.56 9.22 Favored 'General case' 0 N--CA 1.395 -3.207 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.215 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.53 142.6 27.25 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.21 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 72.98 115.23 0.06 Allowed 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.171 1.388 . . . . 0.0 110.953 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.64 119.25 7.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.937 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.56 172.05 14.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.765 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.57 -167.34 2.4 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -68.39 152.38 9.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 170.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 82.27 -9.8 1.15 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.008 1.323 . . . . 0.0 110.7 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -100.8 129.77 46.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -73.2 -100.39 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.642 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 58' ' ' LEU . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 -71.73 146.34 48.21 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 p -93.4 148.81 36.23 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.265 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.16 160.94 0.25 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 124.414 3.409 . . . . 0.0 113.977 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.375 10.3 p 50.47 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 123.27 1.509 . . . . 0.0 113.134 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.3 t -174.3 118.03 0.23 Allowed 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.469 -2.15 . . . . 0.0 106.777 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -128.63 164.51 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.826 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 1.7 pt? -69.86 163.92 24.84 Favored 'General case' 0 N--CA 1.391 -3.404 0 C-N-CA 124.355 1.062 . . . . 0.0 113.278 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 172.1 27.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.488 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.07 49.79 44.7 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -172.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 123.12 26.8 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.728 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -86.67 128.46 39.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.73 113.54 8.63 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.35 151.56 26.28 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.429 2.086 . . . . 0.0 112.783 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.5 t -109.53 123.5 65.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -113.5 94.47 4.88 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 122.699 1.238 . . . . 0.0 108.895 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.32 130.68 42.0 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.802 -1.545 . . . . 0.0 108.021 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 66.38 73.77 0.36 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -84.86 165.16 17.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.661 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.58 129.74 0.2 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.862 0.865 . . . . 0.0 109.792 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 2.4 mp0 -84.32 145.46 28.25 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.437 0.46 . . . . 0.0 111.256 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.55 142.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -82.58 90.66 6.82 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.036 0.922 . . . . 0.0 111.072 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -151.18 -43.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.04 -177.67 3.01 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.269 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 3' ' ' GLU . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.511 ' OG ' HD13 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.516 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.496 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -77.85 139.67 39.3 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -85.38 156.15 59.63 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.495 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 15.6 Cg_exo -73.37 -157.86 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.629 2.22 . . . . 0.0 111.205 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 77' ' ' PRO . 68.9 t 75.03 -45.31 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.65 1.18 . . . . 0.0 112.913 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -74.52 99.07 3.49 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.527 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -133.21 22.3 4.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.242 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.408 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 98.6 mt -70.96 167.22 19.59 Favored 'General case' 0 N--CA 1.401 -2.879 0 CA-C-O 121.429 0.633 . . . . 0.0 110.984 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.88 89.42 4.07 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.06 60.79 0.95 Allowed Glycine 0 C--N 1.291 -1.938 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.857 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 81' ' ' LEU . . . -97.98 126.18 43.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t -86.55 131.9 33.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.723 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.35 113.26 17.91 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.11 155.02 17.07 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.099 1.866 . . . . 0.0 111.65 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.99 108.81 20.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -145.85 154.47 42.02 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.01 177.1 4.93 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.561 0.696 . . . . 0.0 111.549 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -132.28 120.3 21.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.336 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.205 0.941 . . . . 0.0 111.792 178.523 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 120.56 0.219 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 98.95 8.11 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 68.66 103.25 0.05 Allowed 'General case' 0 C--O 1.253 1.274 0 C-N-CA 124.553 1.141 . . . . 0.0 109.379 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 p -78.0 94.01 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 123.371 1.557 . . . . 0.0 110.234 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -83.1 -2.52 55.62 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.715 -171.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -75.47 -20.29 58.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.128 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.7 161.9 13.53 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.633 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.516 HD11 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.633 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.49 ' N ' HD21 ' A' ' 67' ' ' ASN . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.8 108.88 20.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -85.38 137.49 36.74 Favored Pre-proline 0 C--N 1.279 -2.478 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -62.8 114.55 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.123 1.882 . . . . 0.0 111.628 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -98.81 0.71 10.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.7 m 73.75 122.9 0.04 OUTLIER 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.89 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 t30 69.11 179.37 0.24 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.328 1.051 . . . . 0.0 108.475 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' H ' HD21 ' A' ' 81' ' ' LEU . 2.1 pt? -72.88 167.05 21.78 Favored 'General case' 0 N--CA 1.392 -3.351 0 O-C-N 121.214 -0.929 . . . . 0.0 111.117 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.8 113.68 2.8 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.088 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.84 66.33 0.27 Allowed Glycine 0 C--N 1.292 -1.867 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.27 156.41 18.16 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 124.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.46 ' SD ' HD12 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.91 140.12 97.79 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.55 175.07 5.53 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.391 2.727 . . . . 0.0 113.207 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.04 121.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.4 m 66.59 83.77 0.16 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 122.113 0.958 . . . . 0.0 109.408 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 113.79 25.48 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.611 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttp 55.39 91.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.814 0.846 . . . . 0.0 111.886 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.02 -44.28 63.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 83.64 2.16 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.97 93.16 8.0 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.939 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.33 140.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -134.57 79.08 1.78 Allowed 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -135.14 4.21 3.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.684 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -116.62 -171.12 1.95 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.657 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 34' ' ' LEU . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.44 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.56 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 97' ' ' THR . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -93.61 -176.84 4.2 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 t -91.78 149.53 39.26 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.87 174.25 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.63 2.22 . . . . 0.0 111.657 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.98 -28.78 37.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.729 0.776 . . . . 0.0 110.142 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -75.88 105.89 7.17 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 68.24 80.08 0.21 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 109.162 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 82' ' ' ALA . 60.1 tp -113.67 172.88 6.71 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.844 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -143.73 101.99 3.85 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.186 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.83 46.42 3.65 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.35 156.21 23.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.905 0.882 . . . . 0.0 109.26 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.37 119.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.436 ' HE3' HG23 ' A' ' 10' ' ' ILE . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.6 152.99 87.49 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.39 -156.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.694 2.929 . . . . 0.0 110.219 173.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.56 -31.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 t -70.64 92.85 0.88 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 172.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.67 107.71 1.34 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HG2' ' HG2' ' A' ' 100' ' ' GLU . 88.0 tttt -142.66 174.29 10.77 Favored 'General case' 0 N--CA 1.408 -2.541 0 O-C-N 123.416 0.448 . . . . 0.0 110.217 -167.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 12.1 pt-20 -35.11 -42.59 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.902 2.081 . . . . 0.0 115.746 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.749 -179.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.97 107.68 2.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -126.32 96.95 4.87 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.95 142.66 42.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -96.18 79.02 3.14 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.061 0.934 . . . . 0.0 110.188 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -170.74 -48.15 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.627 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 79.0 mt-30 -100.0 164.07 12.16 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.651 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 39' ' ' ILE . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG12 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.404 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -76.39 162.62 27.72 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -72.29 146.1 88.96 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.89 170.76 0.41 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.38 2.72 . . . . 0.0 112.95 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.51 76.18 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 110.967 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -160.31 26.6 0.16 Allowed 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -142.74 157.46 44.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.3 mt -63.42 148.06 49.55 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-O 120.986 0.422 . . . . 0.0 109.868 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.72 72.75 10.14 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.624 0.726 . . . . 0.0 110.792 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.86 47.8 0.08 OUTLIER Glycine 0 C--N 1.297 -1.616 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.48 117.58 29.82 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.54 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t -86.09 137.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.61 122.63 71.69 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HG3' ' HG3' ' A' ' 55' ' ' GLU . 78.4 Cg_exo -48.89 152.65 4.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.191 3.261 . . . . 0.0 113.443 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.1 -53.27 17.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 t -154.3 109.53 3.13 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.655 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -88.13 92.8 9.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HZ2' ' C ' ' A' ' 101' ' ' LYS . 12.4 tmtt? -171.26 95.04 0.18 Allowed 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 -63.74 1.08 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.423 -172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' C ' ' HZ2' ' A' ' 99' ' ' LYS . 93.4 mttt . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.93 83.85 1.65 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.997 0.427 . . . . 0.0 110.926 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.75 89.66 6.73 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.632 0.73 . . . . 0.0 111.158 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.91 128.21 54.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.436 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 8.1 p80 -129.72 82.22 2.06 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -105.36 -26.97 11.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 18.5 mp0 -99.02 -171.49 2.1 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.697 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 HD12 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.697 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.496 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -76.94 102.98 6.63 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 m -100.52 144.88 29.33 Favored Pre-proline 0 C--N 1.292 -1.918 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.318 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.83 112.1 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.912 1.741 . . . . 0.0 112.16 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.39 -16.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 122.35 1.071 . . . . 0.0 108.84 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 p -161.3 111.28 1.65 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.435 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -78.18 93.58 4.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.677 0.751 . . . . 0.0 111.775 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.4 mt -96.96 178.02 5.42 Favored 'General case' 0 N--CA 1.387 -3.596 0 C-N-CA 124.499 1.12 . . . . 0.0 109.079 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.26 96.41 3.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . 81.56 75.55 1.11 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.454 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 8' ' ' LEU . . . -97.67 153.75 18.02 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 122.413 0.285 . . . . 0.0 110.637 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -102.14 130.2 52.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.413 HD12 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.83 118.51 42.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.64 146.02 88.04 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.132 2.555 . . . . 0.0 110.198 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.2 123.12 56.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.303 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.4 m -156.68 122.28 4.78 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -102.89 107.3 18.08 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.151 0.5 . . . . 0.0 110.801 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -155.83 140.47 16.96 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.42 85.01 1.31 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.194 0.997 . . . . 0.0 110.764 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.76 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 102.03 3.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.346 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 66.89 114.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.671 1.188 . . . . 0.0 112.302 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.93 136.31 53.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -101.3 116.69 33.39 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.32 124.62 33.56 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.948 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -80.02 -153.15 0.08 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.637 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.572 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.637 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.41 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m120 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.493 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' H ' HD21 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 -71.54 153.31 42.26 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.1 m -76.87 171.78 11.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.85 176.41 3.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.981 1.788 . . . . 0.0 111.873 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.63 -24.61 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.749 0.785 . . . . 0.0 111.201 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -93.33 100.49 12.82 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -152.11 -172.25 4.17 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.48 178.27 6.07 Favored 'General case' 0 N--CA 1.396 -3.145 0 C-N-CA 123.378 0.671 . . . . 0.0 111.655 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.69 102.45 4.75 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.82 48.9 2.21 Favored Glycine 0 C--N 1.291 -1.917 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.32 129.61 55.52 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.34 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 126.99 90.39 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HG2' ' OE1' ' A' ' 98' ' ' GLU . 33.5 Cg_exo -60.63 139.44 85.82 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.513 2.142 . . . . 0.0 110.309 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.31 -32.99 60.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.026 0.441 . . . . 0.0 110.734 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -138.13 143.26 40.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' OE1' ' HG2' ' A' ' 95' ' ' PRO . 31.9 tt0 -168.01 -59.88 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 176.79 -71.76 0.01 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.523 1.129 . . . . 0.0 108.857 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.72 95.62 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.239 0.526 0 CA-C-O 120.637 0.255 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.51 93.69 0.85 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.23 138.87 42.21 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.541 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.06 -31.54 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 122.184 0.992 . . . . 0.0 110.077 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 65.07 3.63 2.23 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.4 1.88 . . . . 0.0 113.851 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -97.98 -37.21 9.87 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 1.7 mp0 -95.28 -170.82 2.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 171.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.69 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.407 ' HB3' HG23 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.69 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.419 HG21 ' HZ1' ' A' ' 23' ' ' LYS . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 49' ' ' GLY . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.6 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.585 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -78.94 138.69 38.2 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -114.06 138.71 22.99 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.97 112.94 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.079 1.853 . . . . 0.0 110.895 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.03 -21.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m 66.29 20.78 11.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.398 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -166.6 169.73 13.35 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.44 154.36 42.14 Favored 'General case' 0 N--CA 1.387 -3.58 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.92 80.27 1.57 Allowed 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.098 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . -104.17 54.06 0.67 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.1 154.41 19.01 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 60.3 t -84.36 119.49 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.423 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 14' ' ' LEU . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.406 HD13 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.66 145.78 31.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.27 163.36 32.23 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.189 1.926 . . . . 0.0 109.852 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.6 t -73.0 95.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.211 0.529 . . . . 0.0 109.973 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.4 t -170.76 148.7 2.98 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.72 118.85 15.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 69.48 76.05 0.23 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 124.026 0.829 . . . . 0.0 111.25 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.7 76.91 1.09 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.1 116.91 21.41 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -152.7 109.08 3.4 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 120.978 0.418 . . . . 0.0 110.17 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.99 -33.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 122.231 1.015 . . . . 0.0 109.359 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.25 3.5 p-80 -85.42 83.72 7.86 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 122.681 1.229 . . . . 0.0 109.692 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.6 142.98 43.22 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.292 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.46 -147.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.617 ' O ' HG21 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 97' ' ' THR 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' CG ' HG21 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' O ' HG21 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.5 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 -81.09 99.79 8.69 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 m -80.62 141.34 52.08 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.903 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -70.7 115.18 4.11 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.988 1.792 . . . . 0.0 110.334 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.6 t -151.48 143.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -40.21 113.52 0.36 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 124.884 1.365 . . . . 0.0 111.323 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -88.77 107.15 18.81 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.436 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.25 -179.15 4.69 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.12 82.13 7.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.719 0.771 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.67 99.44 1.7 Allowed Glycine 0 C--N 1.295 -1.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.071 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.25 130.01 56.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.91 129.06 68.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.403 HG21 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.56 114.61 65.15 Favored Pre-proline 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -91.61 -178.45 1.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.678 2.252 . . . . 0.0 110.727 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.53 139.21 18.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 48' ' ' ASN . 53.7 m -69.51 119.78 14.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.01 120.34 10.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.3 tttt 70.19 168.54 0.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.339 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 70.28 9.38 6.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.136 0.974 . . . . 0.0 111.798 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.773 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.13 123.43 34.41 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.978 0.418 . . . . 0.0 111.18 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.33 161.73 37.65 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.253 1.021 . . . . 0.0 108.581 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' CG2' HD21 ' A' ' 6' ' ' ASN . 11.8 p -83.42 151.33 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.844 -175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -99.48 10.25 41.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.419 HD21 ' CG2' ' A' ' 4' ' ' VAL . 54.4 m-80 -85.17 -12.31 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.456 0.646 . . . . 0.0 109.786 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -95.67 165.47 12.3 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 34' ' ' LEU . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.693 HD13 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 -77.24 157.48 30.8 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 m -67.38 146.86 98.88 Favored Pre-proline 0 N--CA 1.426 -1.653 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.76 -179.55 1.34 Allowed 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.271 1.981 . . . . 0.0 112.355 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.86 83.44 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 122.592 1.187 . . . . 0.0 110.642 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -109.51 176.75 4.96 Favored 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 113.233 -1.803 . . . . 0.0 107.114 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -90.59 93.82 9.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.828 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' H ' HD21 ' A' ' 81' ' ' LEU . 1.7 pt? -101.36 -175.97 3.01 Favored 'General case' 0 N--CA 1.381 -3.884 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.022 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.23 93.14 3.59 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 120.96 0.41 . . . . 0.0 111.253 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.43 94.75 0.27 Allowed Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.64 102.81 11.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.164 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.22 125.79 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.693 ' SD ' HD13 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.54 115.72 46.36 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.96 -177.89 3.97 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.397 2.065 . . . . 0.0 111.766 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.42 135.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.2 m -73.37 86.02 1.48 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.342 1.068 . . . . 0.0 111.842 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.28 88.22 1.22 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.272 62.0 pttt -89.25 73.93 7.99 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 89.07 7.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? . . . . . 0 N--CA 1.409 -2.484 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -173.326 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.84 110.59 21.81 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.33 99.49 5.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.816 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.75 2.58 10.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.475 1.131 . . . . 0.0 109.011 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.86 88.7 6.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.891 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -101.0 -27.84 13.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -82.84 -176.24 6.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.441 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.627 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.416 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -125.01 175.57 7.25 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 m -114.68 150.42 43.95 Favored Pre-proline 0 N--CA 1.409 -2.487 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.98 133.89 49.98 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.27 1.98 . . . . 0.0 110.312 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p -77.18 -37.56 26.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.322 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 m 55.79 21.68 4.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.945 1.298 . . . . 0.0 112.675 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -147.57 -162.91 1.65 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.6 166.63 16.76 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.93 87.47 2.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.511 0.672 . . . . 0.0 112.031 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.31 -10.53 27.39 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.33 118.66 21.45 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.73 132.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.36 147.18 55.92 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.51 -175.16 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.283 2.655 . . . . 0.0 112.115 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.31 113.66 13.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.48 0.657 . . . . 0.0 111.818 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.0 m -150.95 102.85 3.01 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.13 -58.86 1.88 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -152.56 30.95 0.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.692 1.234 . . . . 0.0 108.207 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.54 92.91 2.42 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.68 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -178.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 138.33 49.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.52 144.72 1.51 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -88.99 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -85.03 74.9 10.45 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -98.75 -35.85 10.02 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.545 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 -109.25 -167.93 1.27 Allowed 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.145 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.636 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' HG21 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 35' ' ' LYS . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.511 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 48' ' ' ASN . 0.8 OUTLIER 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' OE1' ' HB2' ' A' ' 51' ' ' LYS . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' C ' HD13 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.414 HD13 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.34 133.09 50.64 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -75.17 165.95 49.53 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.81 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.33 155.05 1.28 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.467 2.778 . . . . 0.0 112.962 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.74 81.83 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.506 1.146 . . . . 0.0 111.336 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.2 t -101.53 139.74 36.77 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.545 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -76.25 99.62 4.81 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.853 0.835 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.0 -178.6 5.74 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.9 30.11 1.92 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.16 0.505 . . . . 0.0 110.346 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.33 78.45 0.86 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.06 133.22 47.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.421 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.11 134.62 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.465 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' HE2' ' A' ' 88' ' ' MET . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.12 158.69 32.34 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -36.11 146.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.743 2.962 . . . . 0.0 113.623 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.11 -50.89 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.041 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -102.19 95.29 6.22 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.136 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -118.18 108.99 15.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.53 78.79 1.55 Allowed 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -131.08 4.42 4.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.174 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.668 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.463 ' HG2' ' CB ' ' A' ' 19' ' ' ASP . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.407 ' HE1' ' HD3' ' A' ' 46' ' ' LYS . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HD3' ' HE1' ' A' ' 42' ' ' TRP . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 92' ' ' ILE . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.506 ' HA ' HD11 ' A' ' 39' ' ' ILE . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 38' ' ' VAL . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.474 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.464 HG23 ' HD3' ' A' ' 50' ' ' PRO . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 8.2 pt20 . . . . . 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.63 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.739 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 92' ' ' ILE . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG23 ' HD2' ' A' ' 35' ' ' LYS . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 91' ' ' ILE . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 . . . . . 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.435 HG13 HD12 ' A' ' 59' ' ' ILE . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 HD12 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 27' ' ' ASP . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.65 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HA ' HG12 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.505 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 42' ' ' TRP . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 35' ' ' LYS . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' VAL . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 59' ' ' ILE . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 . . . . . 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.492 ' HE2' HG21 ' A' ' 10' ' ' ILE . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.677 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB3' HG21 ' A' ' 90' ' ' VAL . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 56' ' ' VAL . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' HD12 ' A' ' 92' ' ' ILE . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.47 HG23 ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 38' ' ' VAL . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 12' ' ' PHE . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 50' ' ' PRO . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 47.5 mt-30 . . . . . 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.696 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' A' ' 19' ' ' ASP . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.573 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.596 HD12 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD1' HD12 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.573 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 25.8 mp0 . . . . . 0 N--CA 1.41 -2.432 0 CA-C-O 121.461 0.648 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 27' ' ' ASP . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 8' ' ' LEU . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.48 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 92' ' ' ILE . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 39' ' ' ILE . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.446 HG11 HG11 ' A' ' 38' ' ' VAL . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 . . . . . 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.482 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 56' ' ' VAL . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 7.2 pt20 . . . . . 0 N--CA 1.438 -1.026 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.59 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 53' ' ' VAL . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 58' ' ' LEU . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 75' ' ' ARG . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 5.2 mmm180 . . . . . 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 71.3 mt-30 . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.645 ' HD2' HG13 ' A' ' 53' ' ' VAL . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 52' ' ' THR . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 ' HD2' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 38' ' ' VAL . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' HG21 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 9.2 mmm180 . . . . . 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HG3' HG23 ' A' ' 92' ' ' ILE . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 90' ' ' VAL . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 64' ' ' VAL . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 59' ' ' ILE . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.683 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 . . . . . 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 56' ' ' VAL . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 50' ' ' PRO . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 1.7 mp0 . . . . . 0 C--O 1.242 0.673 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 88' ' ' MET . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.738 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 HG13 ' A' ' 91' ' ' ILE . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 29' ' ' THR . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 . . . . . 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t . . . . . 0 N--CA 1.437 -1.075 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.738 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.641 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD13 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 92' ' ' ILE . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD12 ' A' ' 58' ' ' LEU . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 31.3 p30 -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 . . . . . 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 ' HG2' ' A' ' 50' ' ' PRO . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' HG2' ' A' ' 75' ' ' ARG . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 56' ' ' VAL . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 92' ' ' ILE . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 64' ' ' VAL . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 59' ' ' ILE . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 11' ' ' LYS . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.416 HG23 ' HD3' ' A' ' 50' ' ' PRO . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 91' ' ' ILE . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 79.0 mt-30 . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 65' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' LEU . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 91' ' ' ILE . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.449 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.431 HG23 ' HG2' ' A' ' 50' ' ' PRO . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.83 HE21 ' N ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 69' ' ' LYS . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 38' ' ' VAL . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 56' ' ' VAL . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 50' ' ' PRO . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.508 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.444 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 . . . . . 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 14' ' ' LEU . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 65' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' A' ' 51' ' ' LYS . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 92' ' ' ILE . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.597 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 91' ' ' ILE . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 12' ' ' PHE . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.451 ' HB3' HG21 ' A' ' 90' ' ' VAL . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CG ' HG23 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 . . . . . 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.408 HG23 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 94.3 mt-30 . . . . . 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.444 HG13 HD21 ' A' ' 14' ' ' LEU . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.696 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 . . . . . 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.553 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' HB1' ' A' ' 94' ' ' ALA . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 38' ' ' VAL . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB3' HG11 ' A' ' 31' ' ' VAL . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 50' ' ' PRO . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . . . . . . 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 53' ' ' VAL . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 39' ' ' ILE . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.522 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.509 -0.613 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.63 147.57 25.85 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -71.65 134.65 46.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.366 7.2 p 49.68 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 125.393 1.477 . . . . 0.0 113.796 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.266 7.4 p-80 -76.45 81.16 3.17 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.164 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -115.44 85.56 2.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.282 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 -109.97 -168.74 1.36 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.668 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' HG2' ' CB ' ' A' ' 19' ' ' ASP . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.407 ' HE1' ' HD3' ' A' ' 46' ' ' LYS . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HD3' ' HE1' ' A' ' 42' ' ' TRP . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 92' ' ' ILE . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.506 ' HA ' HD11 ' A' ' 39' ' ' ILE . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 38' ' ' VAL . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.474 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 -90.62 175.44 7.04 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 m -86.43 159.48 53.0 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.94 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.93 -177.63 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.38 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.2 -1.54 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.287 1.041 . . . . 0.0 110.71 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 p -83.52 21.57 1.18 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.33 1.062 . . . . 0.0 110.959 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -133.34 141.54 47.98 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.36 -178.62 6.22 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.08 21.2 2.83 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.345 0.593 . . . . 0.0 111.22 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.22 -6.23 55.64 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.054 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.23 115.84 24.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.07 146.08 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.464 HG23 ' HD3' ' A' ' 50' ' ' PRO . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.16 129.94 30.96 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 56.5 Cg_endo -74.74 153.85 43.43 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.71 2.274 . . . . 0.0 112.507 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.9 102.66 5.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m 57.07 84.86 0.09 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HB3' ' HG2' ' A' ' 95' ' ' PRO . 10.5 tp10 -165.81 139.59 4.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -174.0 109.56 0.15 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 123.774 0.671 . . . . 0.0 110.866 -175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 101' ' ' LYS . 13.9 tp10 38.64 -94.1 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.821 1.249 . . . . 0.0 112.46 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 100' ' ' GLU 0.363 0.0 OUTLIER . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.244 0.618 . . . . 0.0 111.199 166.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.43 170.87 2.47 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.61 82.79 6.54 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.23 121.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 122.164 0.983 . . . . 0.0 110.811 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.55 -52.16 0.75 Allowed 'General case' 0 C--N 1.263 -3.163 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.33 95.81 2.6 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.88 0.848 . . . . 0.0 111.045 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 8.2 pt20 -148.42 156.12 42.08 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.63 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.739 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 92' ' ' ILE . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG23 ' HD2' ' A' ' 35' ' ' LYS . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 91' ' ' ILE . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -96.59 173.51 7.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.6 m -114.04 131.49 23.15 Favored Pre-proline 0 N--CA 1.408 -2.557 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.13 122.62 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.224 1.95 . . . . 0.0 110.884 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.58 -10.2 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.744 0.783 . . . . 0.0 110.404 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 t 62.9 32.69 15.59 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.135 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -148.81 147.89 29.29 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.43 -177.91 5.74 Favored 'General case' 0 N--CA 1.393 -3.284 0 C-N-CA 123.749 0.82 . . . . 0.0 109.58 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.99 113.39 4.62 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.07 46.91 3.68 Favored Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.323 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.78 154.46 26.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -85.86 130.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.435 HG13 HD12 ' A' ' 59' ' ' ILE . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 HD12 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.29 132.12 82.3 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.06 160.63 21.69 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.372 2.048 . . . . 0.0 110.106 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -48.88 115.36 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-O 121.915 0.865 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -86.25 70.57 10.54 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.847 0.832 . . . . 0.0 111.151 -173.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 172.88 100.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 126.876 2.07 . . . . 0.0 105.496 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -80.62 90.84 5.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.13 164.46 26.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.058 -0.973 . . . . 0.0 109.705 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.311 178.676 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.5 105.13 4.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.271 11.0 pt-20 43.29 82.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.094 1.357 . . . . 0.0 114.15 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.93 129.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.981 0.896 . . . . 0.0 110.422 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -137.53 30.7 2.6 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.921 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -71.44 93.62 1.18 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.769 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.88 -160.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 172.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 27' ' ' ASP . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.65 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HA ' HG12 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.505 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 42' ' ' TRP . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 35' ' ' LYS . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' VAL . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 59' ' ' ILE . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 -74.41 124.47 26.58 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -71.22 126.95 91.92 Favored Pre-proline 0 N--CA 1.42 -1.966 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.88 109.48 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.14 1.893 . . . . 0.0 110.675 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.5 p -116.78 -43.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -159.21 126.41 4.75 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -84.95 95.96 9.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.48 177.61 6.07 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.846 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 118.67 10.05 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 46.29 7.07 Favored Glycine 0 C--N 1.287 -2.14 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.88 148.74 33.02 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.156 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.23 135.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.492 ' HE2' HG21 ' A' ' 10' ' ' ILE . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 117.2 61.09 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.12 175.39 11.2 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.716 2.277 . . . . 0.0 110.708 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.45 77.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.881 1.324 . . . . 0.0 112.156 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 p -141.11 124.55 16.68 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -150.01 174.23 12.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.674 0.273 . . . . 0.0 110.489 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.63 88.59 7.35 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 101' ' ' LYS . 5.1 pt-20 -100.63 -93.31 0.28 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.559 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 21.4 ptmt . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.684 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.24 0.578 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.82 39.65 26.78 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.153 0.977 . . . . 0.0 109.949 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.82 103.99 7.13 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.909 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 6' ' ' ASN . 26.2 t -121.27 140.33 45.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -85.93 11.36 11.6 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.142 0.972 . . . . 0.0 110.309 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -84.78 -24.34 28.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' OE1' ' HB ' ' A' ' 4' ' ' VAL . 1.9 mp0 -89.69 -178.29 5.49 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.823 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.677 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB3' HG21 ' A' ' 90' ' ' VAL . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 56' ' ' VAL . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' HD12 ' A' ' 92' ' ' ILE . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG23 ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 38' ' ' VAL . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.423 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 32.0 mmt180 -85.55 -176.99 6.31 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.75 158.57 72.97 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' O ' HG12 ' A' ' 78' ' ' VAL . 4.2 Cg_exo -39.2 136.39 0.89 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 124.597 3.531 . . . . 0.0 113.757 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 77' ' ' PRO . 3.3 p 74.75 -3.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 128.669 2.788 . . . . 0.0 111.065 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 69.84 103.01 0.06 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 125.571 1.548 . . . . 0.0 112.092 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 21.5 p-10 -89.52 94.48 9.88 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.734 0.778 . . . . 0.0 109.902 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -81.98 169.99 16.11 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.27 132.6 2.5 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.77 85.8 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.81 154.41 39.19 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.358 0.663 . . . . 0.0 110.075 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t -84.66 133.37 29.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 12' ' ' PHE . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 50' ' ' PRO . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.42 140.84 27.0 Favored Pre-proline 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 36.4 Cg_exo -57.36 140.93 94.52 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 121.958 1.772 . . . . 0.0 110.296 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.74 -27.67 43.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.458 0.647 . . . . 0.0 111.553 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -143.36 100.68 3.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.613 0.72 . . . . 0.0 109.926 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' PRO . 9.2 tp10 -154.37 156.99 37.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -82.55 155.76 24.33 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -100.41 164.77 11.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' A' ' 101' ' ' LYS . 11.6 ptmm? . . . . . 0 C--O 1.265 1.921 0 C-N-CA 124.772 1.229 . . . . 0.0 113.948 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.242 0.681 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.5 172.89 13.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.832 0.349 . . . . 0.0 111.069 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.2 107.1 2.44 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.79 127.31 37.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -112.65 161.85 16.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.43 90.0 2.68 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.578 0.704 . . . . 0.0 110.629 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 47.5 mt-30 -91.73 160.1 15.51 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.696 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' A' ' 19' ' ' ASP . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.573 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.596 HD12 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD1' HD12 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 -64.8 142.01 58.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 m -91.85 126.55 53.21 Favored Pre-proline 0 N--CA 1.422 -1.864 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.91 -179.83 3.45 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.837 2.358 . . . . 0.0 113.861 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.354 8.4 p 49.29 89.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.5 m 51.89 29.63 6.25 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.627 -1.624 . . . . 0.0 114.827 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -97.0 -65.93 0.93 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -92.66 -178.92 5.01 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.603 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.57 91.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.309 1.044 . . . . 0.0 112.35 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 129.64 -47.9 1.0 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.9 155.03 19.05 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.533 -0.833 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.07 133.37 29.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.573 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.63 129.83 26.82 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.54 141.66 97.66 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.148 1.899 . . . . 0.0 110.414 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.36 -40.68 89.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.058 0.456 . . . . 0.0 109.906 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.1 t -137.84 92.72 2.7 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.82 0.819 . . . . 0.0 112.132 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 99.11 0.77 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 66.83 99.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.731 1.212 . . . . 0.0 111.224 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 -2.04 19.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.348 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.406 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.44 140.26 48.35 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.0 mp0 -43.07 108.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.628 1.205 . . . . 0.0 111.382 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.81 138.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.278 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -94.07 177.88 5.83 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.382 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.24 99.08 12.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 25.8 mp0 -94.46 156.24 16.56 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.535 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 27' ' ' ASP . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 8' ' ' LEU . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.48 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 92' ' ' ILE . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 39' ' ' ILE . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.446 HG11 HG11 ' A' ' 38' ' ' VAL . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 -86.12 144.26 27.61 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.4 m -111.91 133.32 21.64 Favored Pre-proline 0 N--CA 1.399 -3.011 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.14 107.92 0.29 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.444 2.096 . . . . 0.0 114.268 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.39 -75.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.944 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.9 m -164.93 139.48 5.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 123.839 0.855 . . . . 0.0 110.174 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -118.05 95.04 4.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.423 0.63 . . . . 0.0 110.07 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.02 170.21 11.3 Favored 'General case' 0 N--CA 1.385 -3.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.251 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.97 91.97 5.29 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.02 24.83 3.46 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.017 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.21 115.85 16.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t -86.66 122.47 38.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.482 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 56' ' ' VAL . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -62.54 118.18 38.42 Favored Pre-proline 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 24.6 Cg_exo -64.74 156.56 60.89 Favored 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 122.961 2.441 . . . . 0.0 113.557 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.78 95.95 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.2 m -68.12 108.98 3.33 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.198 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.84 129.7 20.53 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 68.29 98.95 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.421 1.076 . . . . 0.0 108.988 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.19 105.02 12.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.706 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.247 0.929 0 C-N-CA 124.583 1.153 . . . . 0.0 113.505 175.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 120.345 0.117 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.5 31.0 19.59 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.407 1.083 . . . . 0.0 111.411 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 169.07 9.49 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.568 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.0 t -78.61 105.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -125.25 133.44 52.69 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 179.4 -31.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 7.2 pt20 -75.45 -174.32 2.4 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.982 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.59 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 53' ' ' VAL . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 58' ' ' LEU . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 75' ' ' ARG . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 5.2 mmm180 -105.38 110.57 22.97 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -103.13 123.77 40.72 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.69 139.11 2.19 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.152 1.901 . . . . 0.0 113.89 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.12 -28.86 16.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 122.415 1.103 . . . . 0.0 108.157 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.7 t -156.26 164.8 37.9 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.48 -57.64 11.86 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.38 0.536 . . . . 0.0 111.198 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -102.87 164.7 11.47 Favored 'General case' 1 N--CA 1.374 -4.248 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -179.17 129.32 0.1 Allowed 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.94 54.24 3.8 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.47 153.61 25.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.85 131.09 66.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.22 122.56 57.58 Favored Pre-proline 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.24 117.7 4.63 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 106.039 -2.331 . . . . 0.0 106.039 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.68 129.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -168.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -94.61 91.67 6.68 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.283 38.5 tt0 -67.09 94.15 0.33 Allowed 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -163.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 177.83 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.428 2.691 . . . . 0.0 104.94 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.12 -37.2 0.25 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.916 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.598 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.36 120.37 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.74 1.275 . . . . 0.0 111.595 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.14 113.86 5.02 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.523 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -92.66 -16.96 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 122.606 1.193 . . . . 0.0 109.377 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -113.94 140.01 48.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 113.71 -1.586 . . . . 0.0 106.809 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -91.19 167.39 12.37 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.731 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 71.3 mt-30 -116.68 177.53 4.67 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.561 1.144 . . . . 0.0 108.375 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.645 ' HD2' HG13 ' A' ' 53' ' ' VAL . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 52' ' ' THR . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 ' HD2' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' A' ' 95' ' ' PRO 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 38' ' ' VAL . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' HG21 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 9.2 mmm180 -99.18 151.72 20.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -90.4 166.02 21.23 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 168.14 2.4 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.76 2.307 . . . . 0.0 112.466 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.332 14.4 p 58.64 109.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.938 1.695 . . . . 0.0 112.941 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.8 m -62.91 111.0 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.765 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -95.45 128.74 42.55 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.106 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.24 168.28 18.6 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.465 0.65 . . . . 0.0 111.299 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' HB2' ' H ' ' A' ' 9' ' ' GLU . . . -86.83 78.19 9.11 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.345 0.593 . . . . 0.0 111.784 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.58 -35.51 11.7 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.06 149.35 32.2 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t -86.59 130.18 37.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.02 154.33 60.61 Favored Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HG3' ' OE1' ' A' ' 55' ' ' GLU . 12.6 Cg_exo -67.28 130.06 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.47 80.63 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.706 0.765 . . . . 0.0 111.671 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -85.08 80.56 9.22 Favored 'General case' 0 N--CA 1.395 -3.207 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.215 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.53 142.6 27.25 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.21 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 72.98 115.23 0.06 Allowed 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.171 1.388 . . . . 0.0 110.953 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.64 119.25 7.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.937 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.56 172.05 14.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.765 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.57 -167.34 2.4 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -68.39 152.38 9.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 170.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 82.27 -9.8 1.15 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.008 1.323 . . . . 0.0 110.7 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -100.8 129.77 46.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -73.2 -100.39 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HG3' HG23 ' A' ' 92' ' ' ILE . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 90' ' ' VAL . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 64' ' ' VAL . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 59' ' ' ILE . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.683 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 -71.73 146.34 48.21 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 p -93.4 148.81 36.23 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.265 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.16 160.94 0.25 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 124.414 3.409 . . . . 0.0 113.977 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.375 10.3 p 50.47 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 123.27 1.509 . . . . 0.0 113.134 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.3 t -174.3 118.03 0.23 Allowed 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.469 -2.15 . . . . 0.0 106.777 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -128.63 164.51 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.826 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -69.86 163.92 24.84 Favored 'General case' 0 N--CA 1.391 -3.404 0 C-N-CA 124.355 1.062 . . . . 0.0 113.278 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 172.1 27.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.488 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.07 49.79 44.7 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 123.12 26.8 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.728 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -86.67 128.46 39.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 56' ' ' VAL . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 50' ' ' PRO . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.73 113.54 8.63 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.35 151.56 26.28 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.429 2.086 . . . . 0.0 112.783 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.5 t -109.53 123.5 65.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -113.5 94.47 4.88 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 122.699 1.238 . . . . 0.0 108.895 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.32 130.68 42.0 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.802 -1.545 . . . . 0.0 108.021 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 66.38 73.77 0.36 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -84.86 165.16 17.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.661 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.775 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.58 129.74 0.2 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.862 0.865 . . . . 0.0 109.792 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 2.4 mp0 -84.32 145.46 28.25 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.437 0.46 . . . . 0.0 111.256 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.55 142.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -82.58 90.66 6.82 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.036 0.922 . . . . 0.0 111.072 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -151.18 -43.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 1.7 mp0 -74.04 -177.67 3.01 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.269 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' GLU . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 88' ' ' MET . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.738 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 HG13 ' A' ' 91' ' ' ILE . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 29' ' ' THR . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -77.85 139.67 39.3 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -85.38 156.15 59.63 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.37 -157.86 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.629 2.22 . . . . 0.0 111.205 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t 75.03 -45.31 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.65 1.18 . . . . 0.0 112.913 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -74.52 99.07 3.49 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.527 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -133.21 22.3 4.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.242 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 98.6 mt -70.96 167.22 19.59 Favored 'General case' 0 N--CA 1.401 -2.879 0 CA-C-O 121.429 0.633 . . . . 0.0 110.984 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.88 89.42 4.07 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.06 60.79 0.95 Allowed Glycine 0 C--N 1.291 -1.938 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.857 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . . . -97.98 126.18 43.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t -86.55 131.9 33.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.738 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.35 113.26 17.91 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.11 155.02 17.07 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.099 1.866 . . . . 0.0 111.65 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.99 108.81 20.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -145.85 154.47 42.02 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.01 177.1 4.93 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.561 0.696 . . . . 0.0 111.549 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -132.28 120.3 21.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.336 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.205 0.941 . . . . 0.0 111.792 178.523 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 120.56 0.219 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 98.95 8.11 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 68.66 103.25 0.05 Allowed 'General case' 0 C--O 1.253 1.274 0 C-N-CA 124.553 1.141 . . . . 0.0 109.379 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 p -78.0 94.01 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 123.371 1.557 . . . . 0.0 110.234 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -83.1 -2.52 55.62 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.715 -171.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -75.47 -20.29 58.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.128 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.7 161.9 13.53 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.641 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD13 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 92' ' ' ILE . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD12 ' A' ' 58' ' ' LEU . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 31.3 p30 -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.8 108.88 20.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 10.7 p -85.38 137.49 36.74 Favored Pre-proline 0 C--N 1.279 -2.478 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 76' ' ' SER . 21.3 Cg_exo -62.8 114.55 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.123 1.882 . . . . 0.0 111.628 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -98.81 0.71 10.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.7 m 73.75 122.9 0.04 OUTLIER 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.89 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 t30 69.11 179.37 0.24 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.328 1.051 . . . . 0.0 108.475 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -72.88 167.05 21.78 Favored 'General case' 0 N--CA 1.392 -3.351 0 O-C-N 121.214 -0.929 . . . . 0.0 111.117 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.8 113.68 2.8 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.088 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.84 66.33 0.27 Allowed Glycine 0 C--N 1.292 -1.867 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.27 156.41 18.16 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 124.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 ' HG2' ' A' ' 50' ' ' PRO . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.91 140.12 97.79 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.55 175.07 5.53 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.391 2.727 . . . . 0.0 113.207 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.04 121.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.4 m 66.59 83.77 0.16 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 122.113 0.958 . . . . 0.0 109.408 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 113.79 25.48 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.611 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttp 55.39 91.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.814 0.846 . . . . 0.0 111.886 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.02 -44.28 63.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 83.64 2.16 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.97 93.16 8.0 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.939 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.33 140.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -134.57 79.08 1.78 Allowed 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -135.14 4.21 3.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.684 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -116.62 -171.12 1.95 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' HG2' ' A' ' 75' ' ' ARG . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 56' ' ' VAL . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 97' ' ' THR . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 92' ' ' ILE . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 64' ' ' VAL . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 59' ' ' ILE . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -93.61 -176.84 4.2 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 t -91.78 149.53 39.26 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.87 174.25 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.63 2.22 . . . . 0.0 111.657 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.98 -28.78 37.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.729 0.776 . . . . 0.0 110.142 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -75.88 105.89 7.17 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 68.24 80.08 0.21 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 109.162 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 82' ' ' ALA . 60.1 tp -113.67 172.88 6.71 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.844 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -143.73 101.99 3.85 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.186 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.83 46.42 3.65 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.35 156.21 23.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.905 0.882 . . . . 0.0 109.26 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.37 119.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 11' ' ' LYS . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.416 HG23 ' HD3' ' A' ' 50' ' ' PRO . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 91' ' ' ILE . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -74.6 152.99 87.49 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 17.3 Cg_exo -70.39 -156.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.694 2.929 . . . . 0.0 110.219 173.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.56 -31.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 t -70.64 92.85 0.88 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 172.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.67 107.71 1.34 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' HG2' ' A' ' 100' ' ' GLU . 88.0 tttt -142.66 174.29 10.77 Favored 'General case' 0 N--CA 1.408 -2.541 0 O-C-N 123.416 0.448 . . . . 0.0 110.217 -167.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 12.1 pt-20 -35.11 -42.59 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.902 2.081 . . . . 0.0 115.746 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.749 -179.251 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.97 107.68 2.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -126.32 96.95 4.87 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.95 142.66 42.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -96.18 79.02 3.14 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.061 0.934 . . . . 0.0 110.188 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -170.74 -48.15 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.627 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 79.0 mt-30 -100.0 164.07 12.16 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 65' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' LEU . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 91' ' ' ILE . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.449 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -76.39 162.62 27.72 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -72.29 146.1 88.96 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.89 170.76 0.41 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.38 2.72 . . . . 0.0 112.95 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.51 76.18 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 110.967 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -160.31 26.6 0.16 Allowed 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -142.74 157.46 44.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.3 mt -63.42 148.06 49.55 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-O 120.986 0.422 . . . . 0.0 109.868 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.72 72.75 10.14 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.624 0.726 . . . . 0.0 110.792 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.86 47.8 0.08 OUTLIER Glycine 0 C--N 1.297 -1.616 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.48 117.58 29.82 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.54 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t -86.09 137.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.431 HG23 ' HG2' ' A' ' 50' ' ' PRO . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.61 122.63 71.69 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' HG3' ' HG3' ' A' ' 55' ' ' GLU . 78.4 Cg_exo -48.89 152.65 4.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.191 3.261 . . . . 0.0 113.443 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.1 -53.27 17.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 t -154.3 109.53 3.13 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.655 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -88.13 92.8 9.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -171.26 95.04 0.18 Allowed 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 -63.74 1.08 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.423 -172.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.206 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.93 83.85 1.65 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.997 0.427 . . . . 0.0 110.926 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.75 89.66 6.73 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.632 0.73 . . . . 0.0 111.158 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.91 128.21 54.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 8.1 p80 -129.72 82.22 2.06 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -105.36 -26.97 11.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 18.5 mp0 -99.02 -171.49 2.1 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 69' ' ' LYS . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 38' ' ' VAL . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -76.94 102.98 6.63 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 m -100.52 144.88 29.33 Favored Pre-proline 0 C--N 1.292 -1.918 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.318 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.83 112.1 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.912 1.741 . . . . 0.0 112.16 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.39 -16.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 122.35 1.071 . . . . 0.0 108.84 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 p -161.3 111.28 1.65 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.435 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -78.18 93.58 4.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.677 0.751 . . . . 0.0 111.775 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.4 mt -96.96 178.02 5.42 Favored 'General case' 0 N--CA 1.387 -3.596 0 C-N-CA 124.499 1.12 . . . . 0.0 109.079 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.26 96.41 3.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . 81.56 75.55 1.11 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.454 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' LEU . . . -97.67 153.75 18.02 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 122.413 0.285 . . . . 0.0 110.637 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -102.14 130.2 52.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.83 118.51 42.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.64 146.02 88.04 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.132 2.555 . . . . 0.0 110.198 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.2 123.12 56.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.303 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.4 m -156.68 122.28 4.78 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -102.89 107.3 18.08 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.151 0.5 . . . . 0.0 110.801 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -155.83 140.47 16.96 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.42 85.01 1.31 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.194 0.997 . . . . 0.0 110.764 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.76 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 102.03 3.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.346 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 66.89 114.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.671 1.188 . . . . 0.0 112.302 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.93 136.31 53.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -101.3 116.69 33.39 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.32 124.62 33.56 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.948 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -80.02 -153.15 0.08 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 101' ' ' LYS . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 56' ' ' VAL . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 50' ' ' PRO . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.508 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.444 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 -71.54 153.31 42.26 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.1 m -76.87 171.78 11.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.85 176.41 3.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.981 1.788 . . . . 0.0 111.873 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.63 -24.61 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.749 0.785 . . . . 0.0 111.201 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -93.33 100.49 12.82 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -152.11 -172.25 4.17 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.48 178.27 6.07 Favored 'General case' 0 N--CA 1.396 -3.145 0 C-N-CA 123.378 0.671 . . . . 0.0 111.655 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.69 102.45 4.75 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.82 48.9 2.21 Favored Glycine 0 C--N 1.291 -1.917 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.32 129.61 55.52 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.34 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 14' ' ' LEU . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 126.99 90.39 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.414 ' HG2' ' OE1' ' A' ' 98' ' ' GLU . 33.5 Cg_exo -60.63 139.44 85.82 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.513 2.142 . . . . 0.0 110.309 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.31 -32.99 60.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.026 0.441 . . . . 0.0 110.734 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -138.13 143.26 40.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 95' ' ' PRO . 31.9 tt0 -168.01 -59.88 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 176.79 -71.76 0.01 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.523 1.129 . . . . 0.0 108.857 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.72 95.62 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' H ' ' HG3' ' A' ' 47' ' ' GLU . 29.0 tptp . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.239 0.526 0 CA-C-O 120.637 0.255 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.51 93.69 0.85 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.23 138.87 42.21 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.541 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.06 -31.54 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 122.184 0.992 . . . . 0.0 110.077 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 65.07 3.63 2.23 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.4 1.88 . . . . 0.0 113.851 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -97.98 -37.21 9.87 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 1.7 mp0 -95.28 -170.82 2.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 171.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 65' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' A' ' 51' ' ' LYS . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 92' ' ' ILE . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 91' ' ' ILE . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -78.94 138.69 38.2 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -114.06 138.71 22.99 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.97 112.94 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.079 1.853 . . . . 0.0 110.895 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.03 -21.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m 66.29 20.78 11.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.398 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -166.6 169.73 13.35 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.44 154.36 42.14 Favored 'General case' 0 N--CA 1.387 -3.58 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.92 80.27 1.57 Allowed 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.098 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . -104.17 54.06 0.67 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.1 154.41 19.01 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -84.36 119.49 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 12' ' ' PHE . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.66 145.78 31.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.27 163.36 32.23 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.189 1.926 . . . . 0.0 109.852 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.6 t -73.0 95.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.211 0.529 . . . . 0.0 109.973 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.4 t -170.76 148.7 2.98 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.72 118.85 15.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 69.48 76.05 0.23 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 124.026 0.829 . . . . 0.0 111.25 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.7 76.91 1.09 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.1 116.91 21.41 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -152.7 109.08 3.4 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 120.978 0.418 . . . . 0.0 110.17 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.99 -33.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 122.231 1.015 . . . . 0.0 109.359 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.25 13.5 p80 -85.42 83.72 7.86 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 122.681 1.229 . . . . 0.0 109.692 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.6 142.98 43.22 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.292 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.46 -147.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.451 ' HB3' HG21 ' A' ' 90' ' ' VAL . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 97' ' ' THR 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CG ' HG23 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 -81.09 99.79 8.69 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 38.8 m -80.62 141.34 52.08 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.903 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 76' ' ' SER . 7.4 Cg_exo -70.7 115.18 4.11 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.988 1.792 . . . . 0.0 110.334 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.6 t -151.48 143.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -40.21 113.52 0.36 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 124.884 1.365 . . . . 0.0 111.323 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -88.77 107.15 18.81 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.436 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.25 -179.15 4.69 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.12 82.13 7.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.719 0.771 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.67 99.44 1.7 Allowed Glycine 0 C--N 1.295 -1.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.071 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.25 130.01 56.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.91 129.06 68.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.408 HG23 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.56 114.61 65.15 Favored Pre-proline 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -91.61 -178.45 1.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.678 2.252 . . . . 0.0 110.727 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.53 139.21 18.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASN . 53.7 m -69.51 119.78 14.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.01 120.34 10.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.3 tttt 70.19 168.54 0.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.339 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 70.28 9.38 6.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.136 0.974 . . . . 0.0 111.798 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.773 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.13 123.43 34.41 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.978 0.418 . . . . 0.0 111.18 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.33 161.73 37.65 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.253 1.021 . . . . 0.0 108.581 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 6' ' ' ASN . 11.8 p -83.42 151.33 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.844 -175.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -99.48 10.25 41.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' H ' HG22 ' A' ' 4' ' ' VAL . 24.3 m120 -85.17 -12.31 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.456 0.646 . . . . 0.0 109.786 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 94.3 mt-30 -95.67 165.47 12.3 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.444 HG13 HD21 ' A' ' 14' ' ' LEU . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.44 HD21 ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.696 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 -77.24 157.48 30.8 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 m -67.38 146.86 98.88 Favored Pre-proline 0 N--CA 1.426 -1.653 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.76 -179.55 1.34 Allowed 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.271 1.981 . . . . 0.0 112.355 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.86 83.44 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 122.592 1.187 . . . . 0.0 110.642 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -109.51 176.75 4.96 Favored 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 113.233 -1.803 . . . . 0.0 107.114 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -90.59 93.82 9.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.828 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -101.36 -175.97 3.01 Favored 'General case' 0 N--CA 1.381 -3.884 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.022 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.23 93.14 3.59 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 120.96 0.41 . . . . 0.0 111.253 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.43 94.75 0.27 Allowed Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.64 102.81 11.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.164 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.22 125.79 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.553 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.54 115.72 46.36 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.96 -177.89 3.97 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.397 2.065 . . . . 0.0 111.766 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.42 135.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.2 m -73.37 86.02 1.48 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.342 1.068 . . . . 0.0 111.842 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.28 88.22 1.22 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' ASN 0.272 62.0 pttt -89.25 73.93 7.99 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -172.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 89.07 7.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? . . . . . 0 N--CA 1.409 -2.484 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -173.326 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.84 110.59 21.81 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.33 99.49 5.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.816 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.75 2.58 10.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.475 1.131 . . . . 0.0 109.011 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.86 88.7 6.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.891 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -101.0 -27.84 13.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -82.84 -176.24 6.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.441 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' HB1' ' A' ' 94' ' ' ALA . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 38' ' ' VAL . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB3' HG11 ' A' ' 31' ' ' VAL . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -125.01 175.57 7.25 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 m -114.68 150.42 43.95 Favored Pre-proline 0 N--CA 1.409 -2.487 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.98 133.89 49.98 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.27 1.98 . . . . 0.0 110.312 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p -77.18 -37.56 26.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.322 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 m 55.79 21.68 4.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.945 1.298 . . . . 0.0 112.675 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -147.57 -162.91 1.65 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.6 166.63 16.76 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.93 87.47 2.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.511 0.672 . . . . 0.0 112.031 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.31 -10.53 27.39 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.33 118.66 21.45 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.73 132.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 50' ' ' PRO . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -82.36 147.18 55.92 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 23.1 Cg_exo -65.51 -175.16 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.283 2.655 . . . . 0.0 112.115 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.31 113.66 13.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.48 0.657 . . . . 0.0 111.818 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.0 m -150.95 102.85 3.01 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.13 -58.86 1.88 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -152.56 30.95 0.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.692 1.234 . . . . 0.0 108.207 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.54 92.91 2.42 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.68 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -178.865 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 138.33 49.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.52 144.72 1.51 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -88.99 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -85.03 74.9 10.45 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -98.75 -35.85 10.02 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 -109.25 -167.93 1.27 Allowed 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.145 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 53' ' ' VAL . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 39' ' ' ILE . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.34 133.09 50.64 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -75.17 165.95 49.53 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.81 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.33 155.05 1.28 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.467 2.778 . . . . 0.0 112.962 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.74 81.83 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.506 1.146 . . . . 0.0 111.336 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.2 t -101.53 139.74 36.77 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.545 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -76.25 99.62 4.81 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.853 0.835 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.0 -178.6 5.74 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.9 30.11 1.92 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.16 0.505 . . . . 0.0 110.346 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.33 78.45 0.86 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.06 133.22 47.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.421 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.11 134.62 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.522 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.12 158.69 32.34 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -36.11 146.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.743 2.962 . . . . 0.0 113.623 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.11 -50.89 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.041 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -102.19 95.29 6.22 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.136 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -118.18 108.99 15.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.53 78.79 1.55 Allowed 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -131.08 4.42 4.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.174 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.668 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.463 ' HG2' ' CB ' ' A' ' 19' ' ' ASP . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.407 ' HE1' ' HD3' ' A' ' 46' ' ' LYS . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HD3' ' HE1' ' A' ' 42' ' ' TRP . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 92' ' ' ILE . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.506 ' HA ' HD11 ' A' ' 39' ' ' ILE . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 38' ' ' VAL . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.474 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.464 HG23 ' HD3' ' A' ' 50' ' ' PRO . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 8.2 pt20 . . . . . 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.63 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.739 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 92' ' ' ILE . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG23 ' HD2' ' A' ' 35' ' ' LYS . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 91' ' ' ILE . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 . . . . . 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.435 HG13 HD12 ' A' ' 59' ' ' ILE . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 HD12 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 27' ' ' ASP . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.65 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HA ' HG12 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.505 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 42' ' ' TRP . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 35' ' ' LYS . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' VAL . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 59' ' ' ILE . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 . . . . . 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.492 ' HE2' HG21 ' A' ' 10' ' ' ILE . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.677 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB3' HG21 ' A' ' 90' ' ' VAL . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 56' ' ' VAL . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' HD12 ' A' ' 92' ' ' ILE . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.47 HG23 ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 38' ' ' VAL . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 12' ' ' PHE . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 50' ' ' PRO . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 50.7 mt-30 . . . . . 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.696 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' A' ' 19' ' ' ASP . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.573 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.596 HD12 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD1' HD12 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.573 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 25.8 mp0 . . . . . 0 N--CA 1.41 -2.432 0 CA-C-O 121.461 0.648 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 27' ' ' ASP . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 8' ' ' LEU . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.48 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 92' ' ' ILE . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 39' ' ' ILE . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.446 HG11 HG11 ' A' ' 38' ' ' VAL . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 . . . . . 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.482 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 56' ' ' VAL . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 7.2 pt20 . . . . . 0 N--CA 1.438 -1.026 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.59 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 53' ' ' VAL . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 58' ' ' LEU . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 75' ' ' ARG . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 5.2 mmm180 . . . . . 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 71.3 mt-30 . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.645 ' HD2' HG13 ' A' ' 53' ' ' VAL . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 52' ' ' THR . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 ' HD2' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 38' ' ' VAL . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' HG21 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 9.2 mmm180 . . . . . 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HG3' HG23 ' A' ' 92' ' ' ILE . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 90' ' ' VAL . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 64' ' ' VAL . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 59' ' ' ILE . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.683 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 . . . . . 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 56' ' ' VAL . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 50' ' ' PRO . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 1.7 mp0 . . . . . 0 C--O 1.242 0.673 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 88' ' ' MET . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.738 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 HG13 ' A' ' 91' ' ' ILE . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 29' ' ' THR . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 . . . . . 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t . . . . . 0 N--CA 1.437 -1.075 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.738 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.641 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD13 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 92' ' ' ILE . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD12 ' A' ' 58' ' ' LEU . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.541 ' N ' HD22 ' A' ' 67' ' ' ASN . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 . . . . . 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 ' HG2' ' A' ' 50' ' ' PRO . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' HG2' ' A' ' 75' ' ' ARG . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 56' ' ' VAL . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 92' ' ' ILE . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 64' ' ' VAL . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 59' ' ' ILE . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 11' ' ' LYS . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.416 HG23 ' HD3' ' A' ' 50' ' ' PRO . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 91' ' ' ILE . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 79.0 mt-30 . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 65' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' LEU . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 91' ' ' ILE . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.449 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t . . . . . 0 N--CA 1.44 -0.938 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.431 HG23 ' HG2' ' A' ' 50' ' ' PRO . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 69' ' ' LYS . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 38' ' ' VAL . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 48' ' ' ASN . 12.9 m120 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 56' ' ' VAL . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 50' ' ' PRO . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.508 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.444 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 . . . . . 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 14' ' ' LEU . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 65' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' A' ' 51' ' ' LYS . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 92' ' ' ILE . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.597 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 91' ' ' ILE . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 12' ' ' PHE . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.451 ' HB3' HG21 ' A' ' 90' ' ' VAL . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CG ' HG23 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 . . . . . 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.408 HG23 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 94.3 mt-30 . . . . . 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.444 HG13 HD21 ' A' ' 14' ' ' LEU . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.696 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 . . . . . 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.553 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' HB1' ' A' ' 94' ' ' ALA . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 38' ' ' VAL . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB3' HG11 ' A' ' 31' ' ' VAL . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 50' ' ' PRO . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB1' ' OD1' ' A' ' 48' ' ' ASN . . . . . . . . 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 53' ' ' VAL . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 39' ' ' ILE . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.522 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.509 -0.613 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.63 147.57 25.85 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -71.65 134.65 46.48 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.366 7.2 p 49.68 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 125.393 1.477 . . . . 0.0 113.796 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.266 7.4 p-80 -76.45 81.16 3.17 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.164 -174.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -115.44 85.56 2.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.282 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 26' ' ' PRO . 25.9 mp0 -109.97 -168.74 1.36 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 75' ' ' ARG . 5.5 mp -95.26 127.72 41.53 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.167 -1.413 . . . . 0.0 108.696 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 47.6 mt-10 -91.05 141.59 28.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.937 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.668 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.1 mt -125.5 136.71 59.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -122.22 152.42 40.01 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.258 169.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -104.36 123.71 47.91 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.957 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' HG2' ' CB ' ' A' ' 19' ' ' ASP . 37.2 mtm180 -110.68 123.14 49.44 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.7 153.5 40.04 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.457 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -57.76 -24.83 58.99 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.118 0.967 . . . . 0.0 111.856 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.81 -1.45 47.43 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.991 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.53 3.47 61.18 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -93.08 144.1 25.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 5.8 p-10 -123.36 154.76 38.52 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.346 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 66.3 mt -106.69 141.19 22.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -54.66 141.38 35.79 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 123.778 0.674 . . . . 0.0 113.86 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.65 145.46 63.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.281 2.654 . . . . 0.0 113.627 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 57.1 tttm -127.2 156.7 41.43 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . . . -88.34 127.25 35.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.668 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 75.4 m-85 -126.01 117.17 23.93 Favored Pre-proline 0 C--O 1.25 1.106 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 7' ' ' GLN . 32.0 Cg_exo -61.03 149.6 88.25 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.832 1.688 . . . . 0.0 109.776 172.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.56 -26.72 68.13 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.237 0.541 . . . . 0.0 110.348 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.43 -1.77 38.82 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 136.21 51.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.3 p -80.04 150.26 30.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 94.1 t -64.74 -26.65 40.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -57.48 -48.85 78.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.287 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.4 -34.05 73.92 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.956 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 38' ' ' VAL . 53.6 tp -63.33 -46.3 87.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.601 0.76 . . . . 0.0 109.402 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' HG12 ' A' ' 39' ' ' ILE . 54.6 tttp -62.33 -43.57 98.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.568 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.3 -42.73 92.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.576 0.75 . . . . 0.0 111.084 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.6 m -56.52 -41.77 77.3 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.47 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 58' ' ' LEU . 42.2 t -63.95 -43.02 97.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.994 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 35' ' ' LYS . 26.3 mm -60.84 -33.58 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.171 0.51 . . . . 0.0 110.57 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 m -75.33 -33.03 61.1 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.474 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -79.47 -36.83 38.17 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.262 0.553 . . . . 0.0 111.065 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.407 ' HE1' ' HD3' ' A' ' 46' ' ' LYS . 19.7 t-105 -70.31 132.68 87.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.95 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.99 118.73 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.114 1.876 . . . . 0.0 112.245 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -72.3 -22.24 61.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.97 0.89 . . . . 0.0 109.487 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.2 -13.42 62.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.081 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HD3' ' HE1' ' A' ' 42' ' ' TRP . 61.9 tttp -68.49 122.88 19.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.65 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -96.41 146.48 24.73 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t30 62.09 74.47 0.44 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 122.39 1.09 . . . . 0.0 112.547 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.82 170.83 28.24 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 106.182 -2.767 . . . . 0.0 106.182 174.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 92' ' ' ILE . 88.2 Cg_exo -55.47 172.06 0.53 Allowed 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.533 2.156 . . . . 0.0 112.363 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 pttt 175.98 -16.63 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 124.879 1.272 . . . . 0.0 110.544 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.4 p -104.81 163.96 12.13 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.506 ' HA ' HD11 ' A' ' 39' ' ' ILE . 7.3 p -56.74 -43.22 78.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -16.85 60.47 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.8 -30.01 35.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 38' ' ' VAL . 11.7 p -94.23 132.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -113.1 126.43 55.45 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.42 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 38' ' ' VAL . 2.4 mm? -100.69 123.77 45.36 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 91' ' ' ILE . 84.2 mt -130.31 124.09 56.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.276 0.56 . . . . 0.0 111.775 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.9 t -132.07 130.32 41.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.06 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.01 19.24 11.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.334 1.054 . . . . 0.0 111.616 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 25.37 48.48 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.618 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -131.0 124.99 32.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 p -74.92 133.85 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.474 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.0 mp -81.91 107.89 14.98 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 68' ' ' SER . 8.7 tp10 -71.65 139.25 49.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.2 p-10 -66.42 -21.32 66.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.971 0.415 . . . . 0.0 111.464 -174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 32.6 t -78.74 3.28 17.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.954 0.902 . . . . 0.0 112.037 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -116.81 167.26 11.27 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 75.3 p -105.81 172.85 6.58 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.79 -34.36 69.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -54.36 -33.81 59.86 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.15 -28.91 67.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.935 0.894 . . . . 0.0 112.127 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -110.28 -3.45 16.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.179 0.514 . . . . 0.0 111.058 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 19.2 mmt85 -90.62 175.44 7.04 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 m -86.43 159.48 53.0 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.94 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.93 -177.63 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.38 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.2 -1.54 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.287 1.041 . . . . 0.0 110.71 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 p -83.52 21.57 1.18 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.33 1.062 . . . . 0.0 110.959 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -133.34 141.54 47.98 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.36 -178.62 6.22 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.08 21.2 2.83 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.345 0.593 . . . . 0.0 111.22 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.22 -6.23 55.64 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.054 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.23 115.84 24.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.07 146.08 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.2 m -119.21 136.31 54.26 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 13' ' ' ARG . 31.5 m -115.43 118.98 34.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 50.2 ttp -115.83 142.62 46.53 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.424 -0.173 . . . . 0.0 111.39 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 25.9 m80 -83.96 141.05 31.51 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.03 120.29 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.698 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.557 HD12 HD12 ' A' ' 59' ' ' ILE . 22.4 mt -102.66 135.03 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.762 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.178 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.464 HG23 ' HD3' ' A' ' 50' ' ' PRO . 48.2 mm -87.86 107.98 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.111 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -118.57 110.9 17.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.16 129.94 30.96 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.871 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 56.5 Cg_endo -74.74 153.85 43.43 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.71 2.274 . . . . 0.0 112.507 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.9 102.66 5.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m 57.07 84.86 0.09 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HB3' ' HG2' ' A' ' 95' ' ' PRO . 10.5 tp10 -165.81 139.59 4.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -174.0 109.56 0.15 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 123.774 0.671 . . . . 0.0 110.866 -175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 101' ' ' LYS . 13.9 tp10 38.64 -94.1 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.821 1.249 . . . . 0.0 112.46 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 100' ' ' GLU 0.363 0.0 OUTLIER . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.244 0.618 . . . . 0.0 111.199 166.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.43 170.87 2.47 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.61 82.79 6.54 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.23 121.51 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 122.164 0.983 . . . . 0.0 110.811 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.55 -52.16 0.75 Allowed 'General case' 0 C--N 1.263 -3.163 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.33 95.81 2.6 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.88 0.848 . . . . 0.0 111.045 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.597 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 8.2 pt20 -148.42 156.12 42.08 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.83 138.22 32.23 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt-10 -90.24 122.29 33.03 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.876 0.846 . . . . 0.0 109.715 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.63 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 56.8 mt -115.38 135.48 55.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.115 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.38 145.69 44.97 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.78 131.33 46.72 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.125 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.93 118.32 31.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 92' ' ' ILE . 2.3 mm? -76.1 164.74 25.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.163 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 m -68.06 -22.14 64.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.036 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.61 -2.26 41.77 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.396 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 14.19 61.8 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.987 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -104.68 151.66 23.44 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -133.8 156.25 48.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.484 0.584 . . . . 0.0 111.206 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.43 140.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.98 145.53 33.47 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.764 0.665 . . . . 0.0 114.202 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.9 Cg_endo -66.08 146.16 81.24 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 123.427 2.751 . . . . 0.0 113.596 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -136.65 153.04 51.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -89.16 127.7 35.75 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 119.176 0.898 . . . . 0.0 111.249 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.63 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 30.8 m-85 -126.84 138.77 33.29 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.06 134.11 38.33 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 N-CA-C 108.282 -1.469 . . . . 0.0 108.282 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.739 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 9.8 p-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--O 1.193 -1.87 0 CA-C-O 121.893 0.854 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.27 -2.69 46.18 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.522 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 t -71.69 146.62 48.11 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 120.789 0.328 . . . . 0.0 110.739 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.8 p -64.01 146.58 53.86 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.108 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -26.18 37.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 38.3 t -59.79 -50.6 73.17 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.304 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.42 73.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.832 0.349 . . . . 0.0 110.804 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 34.4 tp -62.27 -50.54 71.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 123.6 0.76 . . . . 0.0 110.062 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.1 ttmt -72.01 -42.51 66.33 Favored 'General case' 0 C--O 1.202 -1.442 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.7 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.68 -30.53 63.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.499 0.19 . . . . 0.0 111.41 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -65.08 -44.22 89.62 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 35' ' ' LYS . 5.6 p -68.67 -36.01 72.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.1 mm -63.22 -38.22 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.474 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.6 m -72.85 -39.83 66.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.01 -34.67 78.61 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.024 0.53 . . . . 0.0 111.809 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 43.6 t-105 -62.18 122.69 74.34 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.9 139.87 78.83 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.983 2.455 . . . . 0.0 113.499 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' GLU . 5.5 ppt_? -68.97 -23.16 64.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.852 0.834 . . . . 0.0 109.586 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 43.4 tt0 -73.93 -23.75 59.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.236 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -74.31 138.39 43.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 mp0 -52.87 146.48 10.66 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.295 0.9 OUTLIER -82.11 67.8 8.26 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -173.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.77 -77.31 0.58 Allowed Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 105.383 -3.087 . . . . 0.0 105.383 166.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 92' ' ' ILE . 83.2 Cg_exo -61.19 94.39 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.36 2.04 . . . . 0.0 109.205 162.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.85 -64.6 1.07 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.156 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -131.54 172.39 12.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.473 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG23 ' HD2' ' A' ' 35' ' ' LYS . 11.6 p -58.45 -27.57 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.412 1.085 . . . . 0.0 110.466 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -76.24 -39.36 54.7 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.091 0.556 . . . . 0.0 110.835 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.1 -27.36 42.91 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 84.0 t -95.93 137.83 22.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.922 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -112.15 145.67 39.42 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 122.376 0.27 . . . . 0.0 110.717 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.17 122.83 42.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 91' ' ' ILE . 41.7 mt -122.8 135.07 64.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.463 0.649 . . . . 0.0 112.165 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 t -138.66 129.53 26.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.23 26.0 13.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 0.0 111.232 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.21 22.11 76.79 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.301 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -128.0 142.27 51.28 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.58 123.68 40.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 74' ' ' TYR 0.253 0.3 OUTLIER -92.49 115.32 27.99 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-O 121.889 0.852 . . . . 0.0 110.51 176.442 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -75.36 137.34 41.01 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.19 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' SER . 27.4 p-10 -60.06 -21.87 61.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.536 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 p -83.28 -6.47 59.48 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.52 165.02 11.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 42.6 p -103.22 163.35 12.3 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t -65.27 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.474 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -55.67 -38.99 70.34 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.16 -24.53 57.92 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.926 0.87 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 53.1 t80 -85.58 -20.37 29.67 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.958 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -96.59 173.51 7.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 124.858 1.263 . . . . 0.0 110.824 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.6 m -114.04 131.49 23.15 Favored Pre-proline 0 N--CA 1.408 -2.557 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.13 122.62 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.224 1.95 . . . . 0.0 110.884 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -122.58 -10.2 8.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.744 0.783 . . . . 0.0 110.404 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 t 62.9 32.69 15.59 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.135 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -148.81 147.89 29.29 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.43 -177.91 5.74 Favored 'General case' 0 N--CA 1.393 -3.284 0 C-N-CA 123.749 0.82 . . . . 0.0 109.58 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.99 113.39 4.62 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.07 46.91 3.68 Favored Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.323 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.78 154.46 26.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -85.86 130.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -97.06 116.18 28.8 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.9 m -106.81 118.43 36.66 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.96 142.77 43.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.209 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -91.17 123.94 35.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.142 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.25 122.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.435 HG13 HD12 ' A' ' 59' ' ' ILE . 43.6 mm -98.34 120.14 47.28 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.825 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.928 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 HD12 ' A' ' 14' ' ' LEU . 46.2 mm -88.14 100.83 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.492 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -102.47 109.49 21.14 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.29 132.12 82.3 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.06 160.63 21.69 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.372 2.048 . . . . 0.0 110.106 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -48.88 115.36 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-O 121.915 0.865 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -86.25 70.57 10.54 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.847 0.832 . . . . 0.0 111.151 -173.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 172.88 100.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 126.876 2.07 . . . . 0.0 105.496 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -80.62 90.84 5.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.13 164.46 26.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.058 -0.973 . . . . 0.0 109.705 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.311 178.676 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.5 105.13 4.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.271 11.0 pt-20 43.29 82.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.094 1.357 . . . . 0.0 114.15 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.93 129.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.981 0.896 . . . . 0.0 110.422 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -137.53 30.7 2.6 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.921 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -71.44 93.62 1.18 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.769 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -92.88 -160.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 172.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 27' ' ' ASP . 5.7 mp -93.84 126.09 38.83 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.251 -1.779 . . . . 0.0 109.2 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.8 mt-10 -90.89 131.28 36.62 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.524 0.678 . . . . 0.0 110.516 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.65 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.4 mt -121.08 141.45 41.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.014 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 63.7 pttt -129.92 158.46 39.48 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 171.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m-85 -117.03 140.1 49.89 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.191 -173.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 19' ' ' ASP . 46.8 mtt180 -114.4 128.46 56.36 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 123.267 0.355 . . . . 0.0 111.426 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.8 173.24 12.7 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -64.7 -23.12 67.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.03 -8.78 59.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.277 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.42 78.96 Favored Glycine 0 C--O 1.24 0.48 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.237 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.2 p -82.85 147.24 28.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 13.4 p-10 -118.98 157.99 26.65 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.456 0.646 . . . . 0.0 111.675 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 63.2 mt -105.78 140.78 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.44 131.41 38.76 Favored Glycine 0 CA--C 1.524 0.605 0 O-C-N 123.908 0.755 . . . . 0.0 112.285 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 145.85 94.81 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.926 2.417 . . . . 0.0 113.565 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 48.3 tttp -130.98 158.71 39.53 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.05 123.86 34.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 118.357 0.526 . . . . 0.0 111.095 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 42.8 m-85 -127.16 153.18 76.75 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.01 143.05 39.73 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 107.953 -1.595 . . . . 0.0 107.953 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' HB ' ' A' ' 71' ' ' VAL . 34.8 t70 -70.26 -31.01 68.19 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.76 12.76 4.39 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.205 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.8 t -74.18 145.79 43.92 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 73.5 p -69.07 153.37 43.87 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 96.9 t -63.37 -30.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.8 t -62.35 -49.68 74.59 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.84 176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.54 70.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.6 tp -61.57 -47.03 87.38 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 123.851 0.861 . . . . 0.0 108.94 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.647 ' HA ' HG12 ' A' ' 38' ' ' VAL . 60.3 mtpt -72.07 -38.12 69.5 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.789 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.4 mm-40 -55.98 -40.72 73.71 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.264 0.554 . . . . 0.0 110.087 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 63.7 m -69.18 -46.75 66.74 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.288 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 35' ' ' LYS . 9.7 p -61.31 -40.95 87.86 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 35' ' ' LYS . 93.4 mt -62.1 -33.4 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.574 0.75 . . . . 0.0 111.448 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.3 m -75.52 -35.97 60.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.022 0.439 . . . . 0.0 111.086 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 37' ' ' THR . 6.6 mm-40 -78.46 -25.53 45.86 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.185 0.517 . . . . 0.0 110.237 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.505 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 72.2 t-105 -83.43 133.57 46.95 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 124.251 1.02 . . . . 0.0 109.36 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 42' ' ' TRP . 31.2 Cg_exo -62.32 129.8 28.1 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.403 2.069 . . . . 0.0 112.459 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -72.48 -22.23 61.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.833 0.825 . . . . 0.0 110.871 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -84.81 0.29 51.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.023 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 42' ' ' TRP . 56.3 tptt -61.2 104.01 0.35 Allowed 'General case' 0 C--O 1.252 1.194 0 CA-C-O 121.52 0.676 . . . . 0.0 111.87 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.08 150.13 31.91 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.224 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.59 16.31 8.7 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.022 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.07 172.97 22.42 Favored Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HD3' ' A' ' 51' ' ' LYS . 24.9 Cg_exo -70.3 166.87 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.756 2.97 . . . . 0.0 112.93 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 2.2 mppt? -130.19 -35.48 1.58 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.501 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.262 18.7 p -131.11 174.8 9.66 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG23 ' HE2' ' A' ' 35' ' ' LYS . 7.5 p -52.35 -34.37 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.765 2.026 . . . . 0.0 114.802 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -77.16 -32.33 56.19 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.007 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' GLN 0.307 1.1 pm0 -92.08 -10.02 40.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.15 116.41 47.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 93' ' ' GLN . 98.2 mttt -107.56 128.65 54.71 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.89 -0.506 . . . . 0.0 112.0 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 35' ' ' LYS . 3.7 mm? -102.5 122.65 44.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' VAL . 35.6 mt -120.27 135.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.383 0.611 . . . . 0.0 112.027 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -136.23 130.21 32.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 14.87 9.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.84 0.856 . . . . 0.0 112.407 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 24.95 30.18 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.544 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 74' ' ' TYR . 58.2 tptt -134.89 134.83 41.1 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 122.819 -0.224 . . . . 0.0 110.65 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 59' ' ' ILE . 58.8 t -74.0 121.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.94 138.65 58.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.222 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.2 tm-20 -95.25 125.56 39.96 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 70.2 m-20 -51.56 -25.24 6.41 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -172.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 8.4 m -81.75 -16.63 50.45 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.994 -0.441 . . . . 0.0 111.981 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.55 165.55 22.85 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.412 0.625 . . . . 0.0 110.734 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 22.6 p -111.37 154.45 24.57 Favored 'General case' 0 N--CA 1.388 -3.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 59.3 t -59.44 -47.09 91.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.83 -33.45 70.42 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.172 0.989 . . . . 0.0 112.718 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -37.2 68.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.752 0.787 . . . . 0.0 109.244 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 63' ' ' LYS . 40.0 t80 -73.98 -41.69 61.57 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.668 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 74.4 mtp180 -74.41 124.47 26.58 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.151 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -71.22 126.95 91.92 Favored Pre-proline 0 N--CA 1.42 -1.966 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.88 109.48 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.14 1.893 . . . . 0.0 110.675 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.5 p -116.78 -43.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -159.21 126.41 4.75 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.126 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -84.95 95.96 9.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.48 177.61 6.07 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.846 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 118.67 10.05 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 46.29 7.07 Favored Glycine 0 C--N 1.287 -2.14 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.88 148.74 33.02 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.156 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.23 135.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.1 m -110.77 136.95 49.06 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.6 m -119.31 126.71 52.11 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.492 ' HE2' HG21 ' A' ' 10' ' ' ILE . 72.7 mtm -119.48 143.43 47.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.438 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -87.58 130.81 34.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.551 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 12' ' ' PHE . 55.2 t -106.13 126.87 61.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.924 0.869 . . . . 0.0 110.155 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp -107.96 128.28 63.42 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 CA-C-N 114.141 -1.391 . . . . 0.0 108.25 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.06 118.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.989 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 51.1 tt0 -104.03 111.12 23.55 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 117.2 61.09 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.764 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.12 175.39 11.2 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.716 2.277 . . . . 0.0 110.708 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.45 77.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.881 1.324 . . . . 0.0 112.156 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 p -141.11 124.55 16.68 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -150.01 174.23 12.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.674 0.273 . . . . 0.0 110.489 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.63 88.59 7.35 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.804 0.811 . . . . 0.0 110.223 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 101' ' ' LYS . 5.1 pt-20 -100.63 -93.31 0.28 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.559 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 21.4 ptmt . . . . . 0 C--N 1.31 -1.116 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.684 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.24 0.578 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.82 39.65 26.78 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.153 0.977 . . . . 0.0 109.949 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.82 103.99 7.13 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.909 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HB ' ' NE2' ' A' ' 7' ' ' GLN . 26.2 t -121.27 140.33 45.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -85.93 11.36 11.6 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.142 0.972 . . . . 0.0 110.309 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -84.78 -24.34 28.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.554 ' NE2' ' HB ' ' A' ' 4' ' ' VAL . 2.3 mp0 -89.69 -178.29 5.49 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.823 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.0 mp -96.01 121.19 37.5 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.6 mt-10 -91.39 133.24 35.63 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.653 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.677 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 64.2 mt -128.27 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.267 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.2 ptpt -116.97 151.81 35.91 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB3' HG21 ' A' ' 90' ' ' VAL . 64.7 m-85 -102.53 117.98 35.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.463 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -117.02 115.92 26.36 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.124 0.488 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 5.2 mp -78.57 152.18 32.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.529 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 p -64.85 -16.83 63.66 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.0 -2.27 43.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.07 11.05 59.14 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.353 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.1 m -101.39 125.5 48.04 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.18 156.03 34.57 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.742 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 59.9 mt -106.76 140.53 24.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 144.09 21.31 Favored Glycine 0 C--O 1.241 0.57 0 O-C-N 123.994 0.809 . . . . 0.0 112.183 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.04 146.02 75.63 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.185 1.923 . . . . 0.0 112.792 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 28.3 mmmt -122.57 165.81 15.84 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.36 122.48 43.81 Favored 'General case' 0 C--N 1.247 -3.868 0 O-C-N 123.817 0.698 . . . . 0.0 109.729 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 61.8 m-85 -122.06 117.61 29.51 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.203 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -59.68 149.18 84.33 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.115 1.876 . . . . 0.0 110.426 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 72' ' ' LYS . 6.4 p-10 -56.91 -31.38 64.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.143 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.97 1.04 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.5 m -80.11 136.88 36.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 70.9 p -82.52 163.43 21.54 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.116 0.484 . . . . 0.0 112.171 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 97.8 t -67.17 -26.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 23.6 t -65.76 -46.83 77.34 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.66 -25.79 64.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.0 tp -64.94 -48.09 75.34 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 39' ' ' ILE . 38.1 mttm -58.76 -47.05 86.0 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.637 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 32' ' ' SER . 18.9 mm-40 -56.88 -36.83 70.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 122.793 0.437 . . . . 0.0 111.363 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -63.03 -41.05 99.42 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 56' ' ' VAL . 46.4 t -60.52 -49.09 85.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 35' ' ' LYS . 37.2 mm -58.56 -33.16 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.086 0.954 . . . . 0.0 110.48 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 m -74.21 -36.65 63.99 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.23 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -86.47 -28.22 23.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.935 0.398 . . . . 0.0 111.292 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -77.28 137.78 64.38 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 123.445 0.698 . . . . 0.0 109.319 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 33.5 Cg_exo -61.87 119.38 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.421 2.08 . . . . 0.0 112.573 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -72.96 -23.29 60.65 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.06 3.23 39.73 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.485 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 60.3 tttm -72.48 160.21 32.68 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 121.859 -0.526 . . . . 0.0 110.033 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG2' ' N ' ' A' ' 48' ' ' ASN . 42.5 tt0 -60.68 177.04 0.33 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.237 1.015 . . . . 0.0 110.154 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 92.4 m-20 -62.68 69.37 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 125.274 1.43 . . . . 0.0 114.737 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.32 -139.53 6.01 Favored Glycine 0 C--N 1.26 -3.694 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 170.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HG2' HD12 ' A' ' 92' ' ' ILE . 16.1 Cg_exo -70.31 149.73 63.84 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 CA-C-N 119.193 1.497 . . . . 0.0 108.964 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 39' ' ' ILE . 87.6 tttt -168.36 -36.87 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.278 24.3 p -122.93 174.66 7.03 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.007 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG23 ' HD3' ' A' ' 35' ' ' LYS . 10.8 p -66.05 -33.95 66.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 125.905 1.682 . . . . 0.0 115.313 -166.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -73.13 -39.09 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.498 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -82.02 -8.87 59.69 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 38' ' ' VAL . 7.2 p -103.25 116.04 46.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.726 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.46 133.45 38.04 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.683 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.9 tm? -112.1 122.24 47.2 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 91' ' ' ILE . 77.3 mt -130.28 131.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.913 0.863 . . . . 0.0 113.129 -171.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -141.69 131.55 24.39 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 69.03 19.54 8.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.812 1.245 . . . . 0.0 110.179 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.67 11.52 85.37 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.591 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.57 141.65 47.91 Favored 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 122.702 0.401 . . . . 0.0 110.381 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.63 132.06 32.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -99.23 137.7 37.38 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.46 127.07 30.32 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.316 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 p-10 -63.93 -23.0 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.632 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -79.59 -6.6 57.4 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.06 165.58 13.93 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.566 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.1 m -107.61 161.75 14.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 89.4 t -64.49 -39.1 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HD2' ' OD2' ' A' ' 27' ' ' ASP . 88.8 tttt -56.41 -52.35 64.95 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.513 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -68.51 -21.29 64.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.89 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -83.88 -8.14 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.473 0.654 . . . . 0.0 110.567 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.423 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 32.0 mmt180 -85.55 -176.99 6.31 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.75 158.57 72.97 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' O ' HG12 ' A' ' 78' ' ' VAL . 4.2 Cg_exo -39.2 136.39 0.89 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 124.597 3.531 . . . . 0.0 113.757 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 77' ' ' PRO . 3.3 p 74.75 -3.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 128.669 2.788 . . . . 0.0 111.065 -175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 69.84 103.01 0.06 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 125.571 1.548 . . . . 0.0 112.092 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 21.5 p-10 -89.52 94.48 9.88 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.734 0.778 . . . . 0.0 109.902 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -81.98 169.99 16.11 Favored 'General case' 0 N--CA 1.384 -3.737 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.27 132.6 2.5 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.77 85.8 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.81 154.41 39.19 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.358 0.663 . . . . 0.0 110.075 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 56.2 t -84.66 133.37 29.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.195 0.521 . . . . 0.0 109.827 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -107.72 137.28 46.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.5 m -108.11 119.8 40.52 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.297 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' HD11 ' A' ' 58' ' ' LEU . 65.9 mtt -110.44 142.69 41.81 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.054 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -84.42 134.13 34.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 12' ' ' PHE . 99.3 t -114.3 121.19 65.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.52 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 HD12 ' A' ' 59' ' ' ILE . 11.7 mt -106.5 130.04 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.727 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.187 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 50' ' ' PRO . 45.1 mm -88.48 103.66 13.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.731 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -97.38 109.64 22.36 Favored 'General case' 0 N--CA 1.406 -2.671 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.621 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.42 140.84 27.0 Favored Pre-proline 0 C--N 1.281 -2.38 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 36.4 Cg_exo -57.36 140.93 94.52 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 121.958 1.772 . . . . 0.0 110.296 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.74 -27.67 43.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.458 0.647 . . . . 0.0 111.553 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -143.36 100.68 3.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.613 0.72 . . . . 0.0 109.926 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 95' ' ' PRO . 9.2 tp10 -154.37 156.99 37.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -82.55 155.76 24.33 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -100.41 164.77 11.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HE2' ' HB2' ' A' ' 101' ' ' LYS . 11.6 ptmm? . . . . . 0 C--O 1.265 1.921 0 C-N-CA 124.772 1.229 . . . . 0.0 113.948 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.242 0.681 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.5 172.89 13.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.832 0.349 . . . . 0.0 111.069 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.2 107.1 2.44 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.79 127.31 37.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -112.65 161.85 16.37 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.525 HD21 ' HB1' ' A' ' 82' ' ' ALA . 53.9 t30 -75.43 90.0 2.68 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.578 0.704 . . . . 0.0 110.629 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 50.7 mt-30 -91.73 160.1 15.51 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.85 125.66 42.82 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.3 mt-10 -91.57 126.98 36.84 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 121.504 0.669 . . . . 0.0 111.013 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.696 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 66.2 mt -123.09 141.83 41.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.861 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 64.1 pttt -126.91 153.53 45.66 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -101.65 121.66 42.45 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' A' ' 19' ' ' ASP . 50.3 ttt180 -120.39 120.75 36.86 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.259 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.77 164.39 7.94 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.668 0.787 . . . . 0.0 110.562 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.573 ' HA ' ' NE2' ' A' ' 89' ' ' HIS . 6.2 t -71.95 -14.67 61.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.088 0.947 . . . . 0.0 109.503 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -79.33 -9.04 59.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.694 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.02 67.59 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.828 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.4 m -88.87 128.45 35.66 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 8.6 p-10 -118.5 158.26 25.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -107.71 141.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.55 142.74 14.62 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 123.58 0.55 . . . . 0.0 114.218 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.16 146.47 64.0 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.677 2.918 . . . . 0.0 114.374 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.9 mptp? -123.85 163.87 20.37 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -98.05 122.42 41.17 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.5 m-85 -120.21 125.27 27.35 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.4 Cg_exo -64.18 149.05 91.08 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.187 1.925 . . . . 0.0 110.817 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.72 -30.29 65.43 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.322 0.582 . . . . 0.0 109.526 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.56 29.0 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.492 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 92.3 m -84.53 139.72 31.94 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 122.085 -0.384 . . . . 0.0 110.195 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 67.9 p -84.43 163.38 19.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.946 0.403 . . . . 0.0 111.908 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.9 t -67.78 -26.17 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.3 t -60.33 -49.78 76.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.16 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -27.37 63.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.32 -46.43 83.56 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' A' ' 38' ' ' VAL . 97.4 mttt -67.3 -38.39 84.92 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.834 175.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 31.2 mm-40 -56.59 -33.45 66.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.408 0.623 . . . . 0.0 110.412 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 79.6 m -72.4 -46.33 55.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.076 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 35' ' ' LYS . 7.8 p -63.62 -40.18 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 120.932 0.396 . . . . 0.0 111.13 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.4 mt -64.07 -34.74 70.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -75.83 -33.78 60.07 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 37' ' ' THR . 44.5 mm-40 -72.98 -25.94 61.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.613 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -87.85 117.19 68.18 Favored Pre-proline 0 N--CA 1.421 -1.914 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.62 123.39 12.61 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.968 1.779 . . . . 0.0 111.371 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -21.03 64.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -68.27 -11.11 58.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.83 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 21.4 tptm -77.36 -174.0 3.11 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 42.9 mt-10 -58.72 159.38 6.78 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 121.85 -0.531 . . . . 0.0 110.297 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -70.47 38.78 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.51 -114.57 0.38 Allowed Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.62 124.16 14.08 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.601 2.201 . . . . 0.0 110.911 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -148.84 -20.58 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.893 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -132.02 172.03 12.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.457 0.646 . . . . 0.0 112.01 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 35' ' ' LYS . 7.6 p -66.63 -28.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.473 1.109 . . . . 0.0 111.453 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.36 -34.09 70.29 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.377 1.071 . . . . 0.0 110.979 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.72 -29.75 16.65 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.944 -169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.75 117.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -93.68 138.64 31.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -109.55 120.46 42.55 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 89' ' ' HIS . 69.1 mt -134.01 135.47 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.35 0.595 . . . . 0.0 111.933 -171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 p -118.82 109.6 16.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.039 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.37 19.4 9.0 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.64 11.77 32.15 Favored Glycine 0 C--N 1.307 -1.073 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.913 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -114.34 129.72 56.65 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.87 125.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.596 HD12 ' CD1' ' A' ' 74' ' ' TYR . 1.8 mm? -95.67 136.26 36.3 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.413 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -91.76 148.05 22.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.4 m-20 -59.58 -32.95 70.84 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.408 . . . . 0.0 114.036 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.0 p -68.65 -23.2 64.39 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' OH ' ' A' ' 74' ' ' TYR . 97.7 mttt -93.83 165.05 12.87 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.206 0.527 . . . . 0.0 111.129 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -99.84 162.84 12.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 97.7 t -59.81 -38.51 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 10.7 tmtt? -51.78 -36.32 47.14 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.429 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -75.57 -23.94 56.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' CD1' HD12 ' A' ' 65' ' ' LEU . 85.1 m-85 -108.49 -0.73 20.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 5.7 ptm180 -64.8 142.01 58.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.407 0.622 . . . . 0.0 112.485 -171.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 m -91.85 126.55 53.21 Favored Pre-proline 0 N--CA 1.422 -1.864 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.91 -179.83 3.45 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 122.837 2.358 . . . . 0.0 113.861 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.354 8.4 p 49.29 89.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.5 m 51.89 29.63 6.25 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.627 -1.624 . . . . 0.0 114.827 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -97.0 -65.93 0.93 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -92.66 -178.92 5.01 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.603 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 6' ' ' ASN . . . 63.57 91.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.309 1.044 . . . . 0.0 112.35 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 129.64 -47.9 1.0 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.9 155.03 19.05 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.533 -0.833 . . . . 0.0 108.797 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.07 133.37 29.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -100.81 121.35 41.54 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.4 m -104.09 117.53 34.49 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.066 0.46 . . . . 0.0 110.565 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.24 133.6 40.37 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.487 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.573 ' NE2' ' HA ' ' A' ' 15' ' ' THR . 11.5 t-80 -88.36 123.1 32.6 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.4 t -107.6 131.45 57.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-O 121.916 0.865 . . . . 0.0 110.843 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.19 130.52 74.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.854 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.2 130.38 56.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.291 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -115.2 108.79 17.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.63 129.83 26.82 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.54 141.66 97.66 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.148 1.899 . . . . 0.0 110.414 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.36 -40.68 89.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.058 0.456 . . . . 0.0 109.906 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.1 t -137.84 92.72 2.7 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.82 0.819 . . . . 0.0 112.132 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 99.11 0.77 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 66.83 99.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.731 1.212 . . . . 0.0 111.224 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 -2.04 19.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.348 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.406 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.44 140.26 48.35 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.0 mp0 -43.07 108.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.628 1.205 . . . . 0.0 111.382 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.81 138.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.278 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -94.07 177.88 5.83 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.382 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.24 99.08 12.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 25.8 mp0 -94.46 156.24 16.56 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.535 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 27' ' ' ASP . 5.6 mp -103.17 129.86 50.19 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.0 mt-10 -91.74 121.85 33.76 Favored 'General case' 0 C--N 1.272 -2.783 0 CA-C-O 121.503 0.668 . . . . 0.0 111.286 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.645 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.9 mt -107.84 136.88 41.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.068 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.0 ptmt -123.05 145.4 48.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -93.64 117.64 30.36 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 109.59 21.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.93 142.53 32.37 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.0 0.429 . . . . 0.0 111.329 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -62.56 -12.85 25.25 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.698 1.199 . . . . 0.0 110.221 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.65 -8.67 58.25 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.994 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.42 68.24 Favored Glycine 0 CA--C 1.501 -0.818 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -99.71 165.03 11.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.31 154.13 36.15 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.073 0.463 . . . . 0.0 110.287 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 69.7 mt -106.89 140.35 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.796 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.39 134.7 50.12 Favored Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.753 0.658 . . . . 0.0 112.352 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.33 142.1 97.33 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 123.273 2.649 . . . . 0.0 113.846 -175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 59.8 mttm -122.0 163.19 19.79 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -91.05 122.11 33.42 Favored 'General case' 0 C--N 1.267 -2.991 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.692 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.4 m-85 -128.67 136.67 29.49 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.0 148.89 87.22 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.294 1.33 . . . . 0.0 109.56 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 8' ' ' LEU . 38.6 t70 -70.09 -21.03 63.17 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.98 0.895 . . . . 0.0 109.635 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.98 6.1 19.86 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.528 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -68.23 138.86 55.9 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.881 0.372 . . . . 0.0 110.793 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.8 p -74.3 144.14 44.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.302 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 92.8 t -65.26 -26.26 39.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 51.0 m -59.66 -41.32 90.32 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.191 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.01 70.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 116.757 -0.202 . . . . 0.0 111.23 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 31' ' ' VAL . 4.5 mm? -58.74 -44.91 90.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 110.299 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.7 mttt -72.02 -36.43 69.7 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 32' ' ' SER . 5.3 mm-40 -61.17 -36.34 79.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.374 0.607 . . . . 0.0 110.446 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.2 m -74.33 -42.21 59.82 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.89 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 35' ' ' LYS . 4.9 p -62.18 -41.14 90.2 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' LYS . 54.1 mt -62.24 -39.95 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.371 0.605 . . . . 0.0 110.691 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.6 m -75.45 -32.49 60.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.972 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -82.83 -34.02 26.98 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.835 0.854 . . . . 0.0 111.858 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.48 ' CZ2' ' HB2' ' A' ' 50' ' ' PRO . 54.5 t-105 -66.47 140.55 96.65 Favored Pre-proline 0 C--O 1.248 1.0 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -33.7 117.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 124.509 3.472 . . . . 0.0 113.264 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -66.39 -27.9 68.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.931 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.84 -16.73 58.09 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.016 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -74.14 144.57 44.81 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.312 0.577 . . . . 0.0 112.209 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -149.36 150.94 33.27 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.3 t30 65.27 21.19 12.01 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.644 1.215 . . . . 0.0 109.045 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -122.14 -165.56 12.54 Favored Glycine 0 N--CA 1.41 -3.098 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB3' HD12 ' A' ' 92' ' ' ILE . 30.7 Cg_exo -72.24 47.53 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 124.208 3.272 . . . . 0.0 113.28 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.1 tttt -97.19 -40.17 8.92 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.308 39.4 p -97.64 172.33 7.78 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 39' ' ' ILE . 7.2 p -68.24 -28.52 41.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.95 1.7 . . . . 0.0 112.413 -172.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -66.63 -39.26 88.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.845 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 12.54 30.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.446 HG11 HG11 ' A' ' 38' ' ' VAL . 81.4 t -118.44 118.68 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 93' ' ' GLN . 13.9 mptt -115.99 143.51 45.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.008 0.523 . . . . 0.0 112.003 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.3 126.71 51.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.751 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 58.3 mt -119.21 122.12 68.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 88' ' ' MET . 40.3 m -125.83 121.92 34.66 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.804 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.31 18.45 11.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.007 0.923 . . . . 0.0 111.479 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.92 59.11 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.734 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 64.1 mttp -103.95 128.69 51.48 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.84 114.97 21.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -78.22 130.97 36.92 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.633 0.73 . . . . 0.0 112.836 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.68 127.92 32.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -67.34 -25.34 65.95 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -73.76 -0.66 16.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.237 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -113.98 166.64 11.4 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 122.765 0.426 . . . . 0.0 110.91 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 72.7 p -101.72 166.87 10.45 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 45.8 t -61.49 -35.44 66.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -52.25 -36.87 53.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.389 1.475 . . . . 0.0 111.415 178.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.63 -28.99 70.29 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.4 -3.78 36.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.2 0.524 . . . . 0.0 110.796 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 40.1 mmt180 -86.12 144.26 27.61 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.261 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.4 m -111.91 133.32 21.64 Favored Pre-proline 0 N--CA 1.399 -3.011 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.14 107.92 0.29 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 122.444 2.096 . . . . 0.0 114.268 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.39 -75.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.944 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.9 m -164.93 139.48 5.13 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 123.839 0.855 . . . . 0.0 110.174 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -118.05 95.04 4.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.423 0.63 . . . . 0.0 110.07 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.02 170.21 11.3 Favored 'General case' 0 N--CA 1.385 -3.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.251 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.97 91.97 5.29 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.02 24.83 3.46 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.017 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.21 115.85 16.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.8 t -86.66 122.47 38.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.537 0.684 . . . . 0.0 110.69 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.3 m -110.02 116.92 32.45 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.8 m -96.79 117.57 31.35 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.482 ' HG2' ' OG ' ' A' ' 60' ' ' SER . 63.4 mtt -101.15 129.73 47.1 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -87.45 123.41 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 56' ' ' VAL . 40.5 t -105.27 120.72 56.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 121.737 0.78 . . . . 0.0 110.689 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.12 126.08 53.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 50' ' ' PRO . 51.1 mm -107.09 130.6 58.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.608 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mp0 -93.77 140.01 30.17 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -62.54 118.18 38.42 Favored Pre-proline 0 C--N 1.275 -2.635 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 24.6 Cg_exo -64.74 156.56 60.89 Favored 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 122.961 2.441 . . . . 0.0 113.557 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.78 95.95 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 57.2 m -68.12 108.98 3.33 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.198 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -142.84 129.7 20.53 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 68.29 98.95 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.421 1.076 . . . . 0.0 108.988 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.19 105.02 12.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.706 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.247 0.929 0 C-N-CA 124.583 1.153 . . . . 0.0 113.505 175.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 120.345 0.117 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.5 31.0 19.59 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.407 1.083 . . . . 0.0 111.411 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 169.07 9.49 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.568 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.0 t -78.61 105.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -125.25 133.44 52.69 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 179.4 -31.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.571 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 7.2 pt20 -75.45 -174.32 2.4 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.982 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.03 139.42 38.61 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 15.7 mp0 -89.57 138.62 31.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 71.8 mt -122.38 139.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.543 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -123.23 148.8 45.47 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.07 118.92 37.91 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -109.42 125.07 52.03 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.237 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 92' ' ' ILE . 2.2 mm? -76.85 159.39 30.09 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.0 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -63.58 -17.32 62.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.45 0.643 . . . . 0.0 110.995 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.86 -8.39 58.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.202 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.13 56.0 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.695 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 m -96.51 147.57 23.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -117.96 146.87 43.68 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -105.77 137.55 35.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.63 127.57 10.43 Favored Glycine 0 C--O 1.25 1.109 0 O-C-N 124.451 1.094 . . . . 0.0 113.575 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 145.38 98.44 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.043 2.495 . . . . 0.0 112.937 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 tttp -130.67 159.42 37.29 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' HG3' ' A' ' 7' ' ' GLN . . . -88.92 129.4 35.62 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.035 0.379 . . . . 0.0 110.063 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.8 m-85 -133.75 124.68 17.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-O 120.918 0.389 . . . . 0.0 110.55 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 7' ' ' GLN . 53.2 Cg_exo -66.08 150.31 85.31 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.227 1.951 . . . . 0.0 109.716 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.15 -22.45 64.71 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.555 0.693 . . . . 0.0 109.471 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 3.39 21.54 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.282 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 62.4 m -70.53 144.05 51.43 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 82.6 p -91.46 161.1 15.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.553 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -69.26 -26.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.59 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 39.0 t -62.6 -49.6 74.58 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.24 -28.09 66.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 110.974 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 38' ' ' VAL . 65.0 tp -64.91 -44.83 88.29 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 53' ' ' VAL . 31.9 mmtp -68.43 -39.78 81.42 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.754 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 32' ' ' SER . 34.1 mm-40 -56.89 -41.88 78.85 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.276 0.56 . . . . 0.0 109.579 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -61.91 -40.92 97.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.392 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 56' ' ' VAL . 89.9 t -61.34 -50.72 79.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.3 mt -57.53 -33.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.545 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 m -75.23 -37.98 60.84 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.996 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -84.08 -27.27 28.37 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -78.94 126.36 82.31 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 87.6 Cg_exo -52.39 129.73 32.96 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.105 2.537 . . . . 0.0 113.332 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -72.44 -25.41 61.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.004 0.907 . . . . 0.0 108.993 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.98 4.72 32.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.245 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -50.63 162.73 0.22 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.342 1.057 . . . . 0.0 112.885 -175.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.99 -160.74 0.05 OUTLIER 'General case' 0 C--O 1.252 1.228 0 C-N-CA 124.541 1.136 . . . . 0.0 109.545 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -71.99 70.5 0.77 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 122.299 1.047 . . . . 0.0 109.345 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.52 -175.23 14.06 Favored Glycine 0 N--CA 1.416 -2.646 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.883 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.61 -179.2 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 124.39 3.394 . . . . 0.0 114.754 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 86.9 tttt -167.31 -68.92 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.409 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.1 p -92.86 172.18 8.5 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 35' ' ' LYS . 6.5 p -48.76 -49.23 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.007 1.323 . . . . 0.0 114.519 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -78.61 -22.37 47.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 111.114 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -31.45 55.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 38' ' ' VAL . 63.2 t -94.27 129.05 45.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.048 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.7 mptt -105.35 123.48 47.94 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 1.7 tm? -111.65 122.45 47.83 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.05 128.11 72.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.313 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -124.26 120.63 32.76 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.86 19.87 11.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.794 0.837 . . . . 0.0 112.013 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 9.95 58.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -117.53 129.54 55.86 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.5 125.17 37.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 58' ' ' LEU . 35.5 mt -83.59 148.31 27.23 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.198 -173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.05 141.84 37.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -21.37 66.82 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -170.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.6 m -87.21 0.61 55.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.118 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -86.25 162.65 18.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.427 0.632 . . . . 0.0 111.108 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 2.6 m -106.25 160.05 15.65 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 75' ' ' ARG . 69.8 t -67.36 -36.74 77.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 39.2 ttpt -52.95 -33.21 49.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.441 1.096 . . . . 0.0 112.339 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.96 -41.11 82.2 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.282 0.563 . . . . 0.0 110.583 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.57 5.64 36.77 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.078 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 5.2 mmm180 -105.38 110.57 22.97 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.813 0.845 . . . . 0.0 111.685 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.2 t -103.13 123.77 40.72 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.69 139.11 2.19 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.152 1.901 . . . . 0.0 113.89 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.12 -28.86 16.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 122.415 1.103 . . . . 0.0 108.157 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.7 t -156.26 164.8 37.9 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.48 -57.64 11.86 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.38 0.536 . . . . 0.0 111.198 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -102.87 164.7 11.47 Favored 'General case' 1 N--CA 1.374 -4.248 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -179.17 129.32 0.1 Allowed 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.94 54.24 3.8 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.47 153.61 25.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.85 131.09 66.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.7 m -102.28 131.41 48.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.3 m -104.76 118.76 37.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.282 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.17 142.45 28.33 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -98.74 123.76 43.17 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.312 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.79 127.15 52.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.804 0.811 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 41.4 mm -97.78 121.11 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.425 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.409 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 14' ' ' LEU . 47.4 mm -88.69 101.75 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.53 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -113.29 110.34 20.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.22 122.56 57.58 Favored Pre-proline 0 C--N 1.27 -2.851 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.275 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.24 117.7 4.63 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 106.039 -2.331 . . . . 0.0 106.039 166.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.68 129.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -168.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -94.61 91.67 6.68 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . 0.283 38.5 tt0 -67.09 94.15 0.33 Allowed 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -163.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt 177.83 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.428 2.691 . . . . 0.0 104.94 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.12 -37.2 0.25 Allowed 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.916 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.36 120.37 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.74 1.275 . . . . 0.0 111.595 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.14 113.86 5.02 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.523 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -92.66 -16.96 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 122.606 1.193 . . . . 0.0 109.377 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -113.94 140.01 48.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 113.71 -1.586 . . . . 0.0 106.809 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -91.19 167.39 12.37 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.731 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 71.3 mt-30 -116.68 177.53 4.67 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.561 1.144 . . . . 0.0 108.375 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.6 pt? -105.53 137.77 42.81 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.055 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 82' ' ' ALA . 38.5 mt-10 -91.49 128.17 37.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.413 0.625 . . . . 0.0 110.712 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.1 mt -119.22 139.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.171 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -122.62 146.29 47.58 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.02 122.19 42.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 40.4 ttm180 -119.01 122.84 43.1 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.158 0.504 . . . . 0.0 110.422 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 92' ' ' ILE . 37.6 mt -76.01 173.44 11.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.193 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.7 p -71.29 -16.7 62.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.535 0.683 . . . . 0.0 110.652 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -79.42 -6.22 56.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.755 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.02 3.48 87.71 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.004 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 p -89.89 135.59 33.54 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -118.73 153.7 33.98 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.6 mt -106.47 141.13 22.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.931 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.76 135.88 19.65 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.184 0.928 . . . . 0.0 114.23 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.72 146.83 80.04 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.59 2.86 . . . . 0.0 113.553 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 26.0 ttpp -135.85 163.52 30.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -88.66 135.94 33.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 56.9 m-85 -133.79 130.1 20.54 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 34.3 Cg_exo -70.19 150.18 65.18 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.475 2.117 . . . . 0.0 111.619 171.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.78 -27.87 65.41 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.381 0.61 . . . . 0.0 109.89 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.74 58.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.239 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m -72.65 137.08 45.83 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.408 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 71.7 p -78.5 158.42 28.6 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.745 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 65' ' ' LEU . 66.0 t -67.69 -26.04 34.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.6 t -62.26 -49.06 77.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.48 65.42 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.11 0.481 . . . . 0.0 111.042 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 68.3 tp -65.61 -42.56 91.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.645 ' HD2' HG13 ' A' ' 53' ' ' VAL . 92.3 mttt -68.97 -37.46 78.79 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.291 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' SER . 35.8 mm-40 -56.86 -37.29 71.12 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.195 0.521 . . . . 0.0 109.798 174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.8 m -61.76 -44.78 96.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.284 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 56' ' ' VAL . 57.5 t -62.52 -46.58 96.06 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.57 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 35' ' ' LYS . 48.3 mt -58.51 -33.82 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.522 0.677 . . . . 0.0 110.787 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.9 m -76.61 -40.53 49.12 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.186 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -31.26 19.14 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -84.82 145.9 45.03 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 21.5 Cg_exo -62.78 105.53 0.44 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 121.022 1.148 . . . . 0.0 110.292 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -67.6 -22.09 65.37 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.053 0.93 . . . . 0.0 109.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.44 -4.47 45.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.107 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 88.1 tttt -81.39 119.55 23.84 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -98.64 167.48 10.76 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.4 t30 67.87 18.71 9.62 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.145 0.974 . . . . 0.0 110.327 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.31 -170.97 20.77 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.09 158.91 23.76 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.842 2.361 . . . . 0.0 111.562 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 52' ' ' THR . 87.2 tttt -159.43 -60.71 0.07 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.25 0.548 . . . . 0.0 109.728 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' VAL . 51.6 p -119.37 175.37 5.85 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.648 0.737 . . . . 0.0 112.464 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 ' HD2' ' A' ' 35' ' ' LYS . 84.2 t -50.42 -30.35 7.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 126.844 2.058 . . . . 0.0 111.627 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.16 -38.26 66.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.206 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' A' ' 95' ' ' PRO 0.326 0.6 OUTLIER -103.39 -11.72 17.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -175.78 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 38' ' ' VAL . 7.1 p -94.81 123.95 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.497 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 35.0 mmtp -115.12 133.76 55.75 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.1 137.92 43.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.667 0.604 . . . . 0.0 110.865 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 19.2 mm -126.81 120.86 56.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 124.641 1.176 . . . . 0.0 110.392 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.5 p -120.41 118.59 30.71 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.19 20.17 12.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.553 0.741 . . . . 0.0 111.753 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.91 0.61 61.97 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.604 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.0 mptp? -104.08 134.12 47.88 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 122.71 0.404 . . . . 0.0 110.278 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 59' ' ' ILE . 14.3 p -86.02 137.54 20.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' HG21 ' A' ' 31' ' ' VAL . 5.1 mp -98.05 121.14 39.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.181 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 12.1 mp0 -71.13 150.19 45.68 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.98 -24.45 67.52 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 m -87.29 5.17 39.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.384 0.611 . . . . 0.0 111.795 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 74.0 mmtt -94.9 165.79 12.28 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.897 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 25.6 p -112.26 167.58 10.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.56 -37.89 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.74 -36.38 67.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.183 1.393 . . . . 0.0 112.238 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.08 -33.86 77.03 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.813 0.339 . . . . 0.0 111.36 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -99.71 3.47 45.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.471 0.653 . . . . 0.0 111.722 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 72' ' ' LYS . 9.2 mmm180 -99.18 151.72 20.68 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.636 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -90.4 166.02 21.23 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.57 168.14 2.4 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.76 2.307 . . . . 0.0 112.466 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.332 14.4 p 58.64 109.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.938 1.695 . . . . 0.0 112.941 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.8 m -62.91 111.0 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.765 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -95.45 128.74 42.55 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.106 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.24 168.28 18.6 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 121.465 0.65 . . . . 0.0 111.299 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' HB2' ' H ' ' A' ' 9' ' ' GLU . . . -86.83 78.19 9.11 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.345 0.593 . . . . 0.0 111.784 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.58 -35.51 11.7 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.06 149.35 32.2 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t -86.59 130.18 37.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -78.55 116.67 19.09 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.2 m -100.52 118.15 36.12 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.401 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.2 mtt -106.7 140.08 40.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 31.2 m170 -93.97 132.66 38.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.95 131.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-O 121.446 0.641 . . . . 0.0 109.376 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 61.1 mt -97.35 121.58 48.02 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.15 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 14' ' ' LEU . 48.7 mm -88.4 108.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.796 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -133.76 126.41 30.58 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.02 154.33 60.61 Favored Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HG3' ' OE1' ' A' ' 55' ' ' GLU . 12.6 Cg_exo -67.28 130.06 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.47 80.63 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.706 0.765 . . . . 0.0 111.671 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -85.08 80.56 9.22 Favored 'General case' 0 N--CA 1.395 -3.207 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.215 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.53 142.6 27.25 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.21 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 72.98 115.23 0.06 Allowed 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.171 1.388 . . . . 0.0 110.953 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.64 119.25 7.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.937 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.56 172.05 14.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.765 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.57 -167.34 2.4 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -68.39 152.38 9.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 170.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 82.27 -9.8 1.15 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.008 1.323 . . . . 0.0 110.7 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -100.8 129.77 46.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -73.2 -100.39 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.12 137.79 54.69 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.228 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 44.5 mt-10 -98.09 137.09 37.39 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 63.9 mt -125.33 132.69 70.78 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.85 156.48 27.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -113.04 130.53 56.12 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.088 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -120.18 129.28 54.04 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.655 0.264 . . . . 0.0 110.5 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.77 167.85 11.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -64.93 -22.35 66.98 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.457 0.646 . . . . 0.0 112.305 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.63 -4.18 50.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.64 3.51 77.49 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 m -72.75 130.8 41.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -118.64 149.97 40.49 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.0 mt -109.66 140.5 28.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 22' ' ' PRO . . . -51.41 143.21 17.32 Favored Glycine 0 CA--C 1.525 0.658 0 O-C-N 124.181 0.926 . . . . 0.0 114.347 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 21' ' ' GLY . 2.2 Cg_endo -79.31 139.06 14.48 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 63.3 mtpt -130.59 163.34 27.33 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 122.91 33.18 Favored 'General case' 0 C--N 1.274 -2.675 0 O-C-N 123.703 0.627 . . . . 0.0 110.39 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 69.0 m-85 -116.31 115.97 39.82 Favored Pre-proline 0 N--CA 1.42 -1.965 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 32.2 Cg_exo -66.77 151.43 82.49 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 123.196 2.597 . . . . 0.0 112.554 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.6 m-20 -51.56 -30.11 19.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.534 0.734 . . . . 0.0 111.375 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 -7.42 58.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.72 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 80.0 m -79.81 140.34 36.88 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 56.2 p -90.29 161.25 15.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.383 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 83.5 t -66.7 -26.1 36.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 60.8 m -64.92 -46.59 81.01 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.18 -25.84 65.44 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.122 0.487 . . . . 0.0 110.856 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 58.3 tp -65.21 -46.12 81.95 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' HG13 ' A' ' 53' ' ' VAL . 95.1 mttt -67.04 -36.72 82.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.285 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 32' ' ' SER . 70.6 mm-40 -57.29 -41.79 80.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.015 175.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.4 m -61.21 -39.57 90.74 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.183 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.14 -49.48 83.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 35' ' ' LYS . 57.9 mt -56.97 -38.74 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.459 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.1 t -64.61 -40.23 95.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.63 -18.96 21.61 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 120.959 0.409 . . . . 0.0 111.722 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -69.28 133.88 89.3 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 92.5 Cg_exo -47.39 121.7 5.75 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.035 2.49 . . . . 0.0 111.589 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -72.13 -29.97 64.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.722 0.773 . . . . 0.0 110.064 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -86.69 3.32 45.27 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.832 -174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -56.03 139.82 45.53 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.431 0.692 . . . . 0.0 110.866 -177.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -124.33 139.62 53.73 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 m120 65.05 20.57 12.1 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.741 1.276 . . . . 0.0 110.822 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.0 155.16 20.13 Favored Glycine 0 N--CA 1.416 -2.636 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HG3' HG23 ' A' ' 92' ' ' ILE . 18.1 Cg_exo -43.7 157.49 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 124.981 3.787 . . . . 0.0 114.339 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -135.61 -53.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.5 p -114.21 174.46 5.94 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG13 ' CD ' ' A' ' 35' ' ' LYS . 85.1 t -47.53 -27.72 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.684 2.394 . . . . 0.0 111.039 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.69 -26.46 57.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.56 -8.43 35.08 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.177 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 90' ' ' VAL . 72.7 t -118.3 124.04 72.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -115.46 144.82 43.26 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.9 mm? -112.19 122.79 48.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 64' ' ' VAL . 1.7 mp -115.86 128.69 73.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.152 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.1 p -135.95 130.87 34.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.8 18.23 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.153 0.981 . . . . 0.0 111.013 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.98 18.71 64.57 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.54 132.93 51.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 59' ' ' ILE . 44.0 t -80.47 133.92 28.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HG ' ' CE1' ' A' ' 74' ' ' TYR . 6.2 mp -84.0 124.24 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.8 tt0 -69.55 129.26 39.2 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 3.5 p-10 -64.96 -24.08 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.239 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 38.6 m -82.57 3.15 29.77 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.683 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -98.75 163.02 12.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.1 m -101.76 165.08 11.4 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 94.0 t -63.07 -38.0 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 59.8 tttp -62.37 -33.9 75.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.13 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.99 -34.0 61.91 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 120.743 0.306 . . . . 0.0 111.204 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 61.8 t80 -76.37 -34.24 58.9 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.36 -175.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 30.0 mtm105 -71.73 146.34 48.21 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 121.442 0.639 . . . . 0.0 111.741 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 p -93.4 148.81 36.23 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.265 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.16 160.94 0.25 Allowed 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 124.414 3.409 . . . . 0.0 113.977 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.375 10.3 p 50.47 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 123.27 1.509 . . . . 0.0 113.134 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.3 t -174.3 118.03 0.23 Allowed 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.469 -2.15 . . . . 0.0 106.777 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -128.63 164.51 22.73 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.826 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -69.86 163.92 24.84 Favored 'General case' 0 N--CA 1.391 -3.404 0 C-N-CA 124.355 1.062 . . . . 0.0 113.278 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 172.1 27.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.224 -1.807 . . . . 0.0 107.488 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.07 49.79 44.7 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 123.12 26.8 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.728 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -86.67 128.46 39.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.002 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.9 m -123.59 135.82 54.18 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.5 m -112.44 119.03 36.84 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtt -104.48 137.25 42.63 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.182 0.515 . . . . 0.0 110.697 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -89.52 124.98 35.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 56' ' ' VAL . 48.2 t -93.85 125.14 46.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 121.771 0.796 . . . . 0.0 110.681 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.09 115.98 47.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.455 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 50' ' ' PRO . 2.4 mp -90.66 130.09 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.854 -176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.92 123.7 36.38 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.73 113.54 8.63 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 124.051 0.844 . . . . 0.0 110.436 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.35 151.56 26.28 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.429 2.086 . . . . 0.0 112.783 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.5 t -109.53 123.5 65.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -113.5 94.47 4.88 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 122.699 1.238 . . . . 0.0 108.895 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.32 130.68 42.0 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.802 -1.545 . . . . 0.0 108.021 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 66.38 73.77 0.36 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -84.86 165.16 17.94 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.661 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.775 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.58 129.74 0.2 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.862 0.865 . . . . 0.0 109.792 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 2.4 mp0 -84.32 145.46 28.25 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.437 0.46 . . . . 0.0 111.256 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.55 142.79 12.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -82.58 90.66 6.82 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.036 0.922 . . . . 0.0 111.072 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -151.18 -43.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 1.7 mp0 -74.04 -177.67 3.01 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.269 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.17 134.73 40.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.0 mt-10 -91.5 128.62 37.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 68.3 mt -116.95 136.56 53.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -117.69 137.21 52.82 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.12 117.91 30.79 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 48.7 mtp180 -112.28 130.86 55.8 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.112 0.482 . . . . 0.0 110.49 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.09 167.65 13.99 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.614 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.3 p -70.71 -17.05 62.83 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.32 -2.07 47.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.939 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.69 3.57 83.54 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.589 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -89.78 134.48 34.16 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 5.4 p-10 -131.13 163.11 28.41 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.388 0.613 . . . . 0.0 112.314 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.96 138.49 29.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.21 138.3 22.33 Favored Glycine 0 C--O 1.245 0.816 0 O-C-N 124.331 1.019 . . . . 0.0 113.211 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 42.9 Cg_endo -73.97 141.57 30.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.558 2.172 . . . . 0.0 113.879 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 4.1 mppt? -132.37 163.57 28.4 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.754 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' GLU . . . -89.69 123.23 33.54 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.285 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 33.4 m-85 -121.08 129.51 25.25 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -65.18 146.3 86.29 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.024 1.149 . . . . 0.0 109.945 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.3 -16.01 62.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.645 0.736 . . . . 0.0 110.017 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.84 -0.13 37.53 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.236 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 71' ' ' VAL . 41.2 m -76.32 139.37 41.01 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 81.2 p -82.69 159.38 22.62 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 120.722 0.296 . . . . 0.0 110.644 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.18 -27.41 40.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.5 m -60.1 -49.14 78.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.031 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.92 -30.98 61.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.73 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 88' ' ' MET . 67.8 tp -62.88 -48.48 78.82 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' HG12 ' A' ' 39' ' ' ILE . 5.0 tppp? -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.494 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.21 -40.23 73.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.162 1.385 . . . . 0.0 109.237 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 m -63.14 -42.3 99.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.965 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.19 -42.56 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 35' ' ' LYS . 30.7 mm -62.68 -33.52 60.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.6 t -76.5 -40.18 50.92 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.937 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.72 -40.11 73.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.381 0.673 . . . . 0.0 112.153 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 16.8 t-105 -82.99 128.52 65.08 Favored Pre-proline 0 N--CA 1.427 -1.621 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.26 111.54 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.414 2.076 . . . . 0.0 112.836 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -64.45 -21.96 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.341 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.38 -16.04 63.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.05 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.25 134.49 38.57 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.772 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.8 156.34 41.42 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 69.21 13.98 8.62 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.3 -75.34 0.27 Allowed Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 107.081 -2.407 . . . . 0.0 107.081 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 7.1 Cg_endo -97.14 -170.54 0.15 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.499 2.133 . . . . 0.0 109.811 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -165.93 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 p -132.85 173.47 11.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.265 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -50.75 -41.61 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 124.43 1.092 . . . . 0.0 110.562 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.94 -39.08 92.96 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.734 1.213 . . . . 0.0 112.54 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -82.58 -24.94 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.5 t -93.84 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.03 144.76 32.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.078 0.466 . . . . 0.0 111.3 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.738 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.4 tm? -120.8 128.05 52.5 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 HG13 ' A' ' 91' ' ' ILE . 35.2 mt -134.14 129.12 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.641 0.734 . . . . 0.0 112.216 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' HD11 ' A' ' 65' ' ' LEU . 77.7 p -130.12 129.66 43.81 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.74 20.37 12.19 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.606 0.717 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' C ' ' HE3' ' A' ' 63' ' ' LYS . . . 84.22 8.8 83.13 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.669 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HE3' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -103.45 139.36 38.93 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.18 121.71 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 ' OG ' ' A' ' 60' ' ' SER . 7.1 mp -82.23 113.85 20.33 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.322 0.582 . . . . 0.0 110.779 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.31 145.63 37.28 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -64.38 -27.12 68.79 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -170.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -84.03 3.19 35.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.206 0.527 . . . . 0.0 111.201 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -92.76 165.59 12.86 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.412 0.625 . . . . 0.0 111.694 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 4.1 m -113.65 162.42 16.26 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 29' ' ' THR . 95.2 t -63.21 -40.64 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.625 0.726 . . . . 0.0 109.521 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -52.85 -33.26 48.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 112.634 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.12 -32.94 74.41 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 67.9 m-85 -99.14 -13.77 19.64 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.649 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -77.85 139.67 39.3 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 120.996 0.427 . . . . 0.0 111.213 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -85.38 156.15 59.63 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.37 -157.86 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.629 2.22 . . . . 0.0 111.205 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t 75.03 -45.31 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.65 1.18 . . . . 0.0 112.913 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -74.52 99.07 3.49 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.527 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -133.21 22.3 4.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.242 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 98.6 mt -70.96 167.22 19.59 Favored 'General case' 0 N--CA 1.401 -2.879 0 CA-C-O 121.429 0.633 . . . . 0.0 110.984 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.88 89.42 4.07 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.06 60.79 0.95 Allowed Glycine 0 C--N 1.291 -1.938 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.857 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 81' ' ' LEU . . . -97.98 126.18 43.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 36.0 t -86.55 131.9 33.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.293 0.568 . . . . 0.0 110.533 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.4 m -117.89 137.44 52.8 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.21 1.004 . . . . 0.0 108.704 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 m -95.54 120.27 35.49 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.738 ' SD ' HD11 ' A' ' 58' ' ' LEU . 53.7 ttm -121.16 142.75 49.59 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -105.77 137.19 44.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.461 0.648 . . . . 0.0 112.053 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.83 131.61 59.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.569 HG13 HD12 ' A' ' 59' ' ' ILE . 38.1 mm -107.43 115.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.865 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.56 108.14 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.182 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -111.97 111.68 22.79 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.35 113.26 17.91 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 124.067 0.855 . . . . 0.0 110.864 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.11 155.02 17.07 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.099 1.866 . . . . 0.0 111.65 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.99 108.81 20.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -145.85 154.47 42.02 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.01 177.1 4.93 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.561 0.696 . . . . 0.0 111.549 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -132.28 120.3 21.95 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.336 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.205 0.941 . . . . 0.0 111.792 178.523 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 120.56 0.219 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 98.95 8.11 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 68.66 103.25 0.05 Allowed 'General case' 0 C--O 1.253 1.274 0 C-N-CA 124.553 1.141 . . . . 0.0 109.379 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 p -78.0 94.01 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 123.371 1.557 . . . . 0.0 110.234 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -83.1 -2.52 55.62 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.715 -171.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -75.47 -20.29 58.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.128 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.7 161.9 13.53 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -102.5 138.63 39.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -89.47 136.67 32.9 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.422 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.641 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 60.0 mt -128.1 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.527 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -124.43 150.32 45.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -101.59 117.88 35.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 14' ' ' LEU . 2.5 tmm_? -108.02 113.82 27.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.674 0.749 . . . . 0.0 109.414 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD13 ' CG1' ' A' ' 90' ' ' VAL . 2.9 mm? -67.62 148.56 51.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.187 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -65.52 -18.4 65.29 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.709 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.52 -6.15 56.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.909 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.94 3.16 60.72 Favored Glycine 0 C--N 1.322 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.858 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.2 t -94.25 158.28 15.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -140.79 158.34 44.1 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.92 140.52 23.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.92 141.03 10.6 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 124.129 0.893 . . . . 0.0 113.347 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.67 145.61 33.06 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.995 2.463 . . . . 0.0 113.783 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 13.8 mptt -130.03 163.36 26.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.543 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.24 125.07 35.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 48.9 m-85 -123.13 125.48 26.22 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 36.1 Cg_exo -65.6 148.4 87.24 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.11 1.206 . . . . 0.0 109.369 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 1.9 p30 -65.96 -20.29 66.15 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.311 0.577 . . . . 0.0 111.767 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.12 -4.9 52.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.033 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 37.4 m -71.55 142.53 50.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 34.8 p -79.05 152.76 30.69 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 75.2 t -65.38 -26.48 39.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.714 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -57.9 -49.63 76.06 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.21 -29.02 67.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 55.5 tp -63.78 -48.23 77.75 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.0 mtpt -69.73 -36.79 76.15 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.367 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.69 -32.23 73.65 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -65.8 -37.09 85.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 58.3 t -59.46 -47.73 89.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 35' ' ' LYS . 42.6 mm -63.77 -34.55 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.797 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -66.84 -35.36 79.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -89.89 -3.48 58.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 123.242 0.617 . . . . 0.0 111.671 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -104.56 141.23 22.1 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.55 109.57 2.66 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.656 1.571 . . . . 0.0 111.706 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -22.19 61.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.375 0.607 . . . . 0.0 109.687 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.8 -18.55 65.2 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.576 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.81 113.6 2.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.794 0.684 . . . . 0.0 111.219 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.15 129.53 36.11 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.1 t30 63.23 66.16 0.73 Allowed 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 122.123 0.963 . . . . 0.0 110.499 -173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.86 154.11 20.06 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' HD12 ' A' ' 92' ' ' ILE . 69.1 Cg_exo -48.48 111.18 0.42 Allowed 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.866 3.044 . . . . 0.0 114.788 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 96.9 mttt -98.89 -27.24 13.99 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.395 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 80.3 p -131.42 171.34 13.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.1 -30.18 49.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 124.575 1.15 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.6 -33.34 73.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.774 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' THR . 7.6 pt-20 -97.61 6.96 47.3 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.98 134.32 57.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.73 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -115.48 121.31 42.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 88' ' ' MET . 2.2 tm? -107.28 124.48 49.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.15 131.46 72.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 122.92 0.488 . . . . 0.0 110.46 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.9 p -132.08 130.75 41.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.48 17.15 10.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.223 1.009 . . . . 0.0 111.252 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.8 18.23 54.89 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.468 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.83 130.68 42.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -73.7 134.54 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD12 ' A' ' 58' ' ' LEU . 42.9 mt -92.05 136.32 33.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.148 0.499 . . . . 0.0 112.239 -175.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.46 117.94 20.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.413 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -61.43 -24.11 66.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.541 ' N ' HD22 ' A' ' 67' ' ' ASN . 13.0 m -74.28 -10.61 59.76 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.351 0.596 . . . . 0.0 111.63 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.51 166.54 11.31 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 123.201 0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 67.9 p -99.87 169.83 8.95 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 27' ' ' ASP . 68.6 t -65.81 -31.32 53.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -58.43 -35.94 72.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.127 1.371 . . . . 0.0 109.93 177.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.12 -27.07 69.13 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.804 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -109.97 4.64 21.62 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.205 0.526 . . . . 0.0 111.014 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.8 108.88 20.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 123.746 0.818 . . . . 0.0 109.512 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 10.7 p -85.38 137.49 36.74 Favored Pre-proline 0 C--N 1.279 -2.478 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 76' ' ' SER . 21.3 Cg_exo -62.8 114.55 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.123 1.882 . . . . 0.0 111.628 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -98.81 0.71 10.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.7 m 73.75 122.9 0.04 OUTLIER 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.89 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 t30 69.11 179.37 0.24 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.328 1.051 . . . . 0.0 108.475 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -72.88 167.05 21.78 Favored 'General case' 0 N--CA 1.392 -3.351 0 O-C-N 121.214 -0.929 . . . . 0.0 111.117 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.8 113.68 2.8 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.088 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.84 66.33 0.27 Allowed Glycine 0 C--N 1.292 -1.867 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.27 156.41 18.16 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 124.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.052 0.929 . . . . 0.0 110.217 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 m -100.87 126.37 47.48 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.734 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.0 m -97.68 118.65 34.69 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 58' ' ' LEU . 64.6 mtt -112.61 139.35 48.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.754 0.311 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -88.06 123.65 32.96 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.358 0.663 . . . . 0.0 110.228 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 14' ' ' LEU . 8.0 p -112.66 136.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-O 121.546 0.689 . . . . 0.0 110.67 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mt -112.96 119.26 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 ' HG2' ' A' ' 50' ' ' PRO . 48.5 mm -97.17 123.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.296 -176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -129.73 124.54 33.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.91 140.12 97.79 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 123.893 0.746 . . . . 0.0 110.583 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.55 175.07 5.53 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.391 2.727 . . . . 0.0 113.207 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.04 121.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.4 m 66.59 83.77 0.16 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 122.113 0.958 . . . . 0.0 109.408 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 113.79 25.48 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.611 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttp 55.39 91.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.814 0.846 . . . . 0.0 111.886 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.02 -44.28 63.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 83.64 2.16 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.97 93.16 8.0 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.939 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -103.33 140.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -134.57 79.08 1.78 Allowed 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -135.14 4.21 3.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.684 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -116.62 -171.12 1.95 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' HG2' ' A' ' 75' ' ' ARG . 5.5 mp -94.34 128.51 40.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.661 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 37.7 mt-10 -94.09 126.9 39.59 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.691 0.758 . . . . 0.0 111.387 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 65.2 mt -128.24 143.88 39.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.457 -177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 60.1 pttt -119.35 147.6 44.15 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 171.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -95.31 128.29 42.04 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.823 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -111.07 123.75 50.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.914 0.387 . . . . 0.0 110.574 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.73 171.48 15.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.46 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -72.14 -21.75 61.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.922 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.33 1.34 41.65 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.61 4.56 73.0 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.357 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -91.55 142.14 27.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.65 154.67 46.04 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 121.204 0.525 . . . . 0.0 111.403 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 64.2 mt -105.77 140.97 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.67 138.34 14.5 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.151 0.907 . . . . 0.0 114.441 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.77 146.23 83.07 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.265 2.643 . . . . 0.0 113.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 58.2 mtpt -138.27 163.84 30.74 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.572 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.28 123.18 33.85 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.956 0.785 . . . . 0.0 110.469 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.6 m-85 -116.55 124.6 29.25 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.95 145.67 96.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.079 1.186 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 6.5 p-10 -64.95 -32.84 74.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.304 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.09 2.07 25.39 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.9 m -70.81 139.05 50.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.6 p -81.15 156.34 25.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.581 0.229 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 97.3 t -65.22 -27.42 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.118 0.485 . . . . 0.0 110.43 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.28 -45.09 85.86 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.01 -27.31 63.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.273 0.559 . . . . 0.0 110.376 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 60.1 tp -63.04 -44.5 95.71 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 99.0 mttt -67.95 -37.07 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.39 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.23 -36.08 74.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.301 0.572 . . . . 0.0 109.766 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.9 m -66.57 -39.13 88.33 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 56' ' ' VAL . 57.9 t -61.6 -44.94 99.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.336 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 35' ' ' LYS . 55.9 mt -56.63 -35.32 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HA ' HH21 ' A' ' 44' ' ' ARG . 31.9 t -72.33 -37.66 68.83 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.26 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 52.1 mm-40 -87.77 -34.95 18.13 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -63.41 137.39 97.06 Favored Pre-proline 0 C--O 1.247 0.928 0 C-N-CA 123.986 0.915 . . . . 0.0 110.434 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 31.8 Cg_exo -61.97 107.75 0.58 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.045 1.83 . . . . 0.0 110.012 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 91.4 mtt180 -72.22 -22.78 61.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.209 -174.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -79.03 -11.67 60.01 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.371 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 55.7 tttm -67.02 134.32 51.68 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.782 0.325 . . . . 0.0 111.053 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.42 173.76 6.16 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 97' ' ' THR . 3.4 m-20 57.2 19.78 5.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.289 0.635 . . . . 0.0 112.385 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.55 169.7 33.95 Favored Glycine 0 N--CA 1.401 -3.64 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 92' ' ' ILE . 36.8 Cg_exo -49.98 -177.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.719 3.613 . . . . 0.0 116.044 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 44' ' ' ARG . 40.0 ttmt -168.17 -44.53 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.548 -1.66 . . . . 0.0 107.638 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.6 p -108.72 171.56 7.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 35' ' ' LYS . 4.0 p -58.8 -33.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.585 1.954 . . . . 0.0 113.481 -174.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -70.74 -27.93 64.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 111.811 0.301 . . . . 0.0 111.811 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 28.5 mm-40 -98.48 -9.95 24.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.524 HG11 HG11 ' A' ' 38' ' ' VAL . 91.9 t -100.01 125.71 53.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -116.04 133.15 56.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 176.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.59 136.88 41.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.537 0.208 . . . . 0.0 110.645 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 64' ' ' VAL . 17.7 mm -121.21 127.49 75.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.996 0.918 . . . . 0.0 111.717 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -140.13 126.54 20.13 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.33 24.03 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.233 0.613 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.58 9.51 86.98 Favored Glycine 0 C--O 1.226 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.093 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -110.17 130.24 55.57 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 122.689 -0.301 . . . . 0.0 110.482 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 59' ' ' ILE . 46.6 t -72.32 121.07 21.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 7.8 mp -66.89 130.83 44.42 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.324 0.39 . . . . 0.0 111.715 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.45 133.44 33.74 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.373 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 75.7 m-20 -56.77 -30.73 63.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.899 1.279 . . . . 0.0 112.402 -174.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 m -73.03 -22.3 60.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -98.07 166.29 11.5 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 29.9 p -90.85 163.12 14.53 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.017 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 61.0 t -65.51 -30.35 49.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 55.2 tttp -57.12 -33.96 67.88 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.692 1.597 . . . . 0.0 111.35 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.2 -30.3 70.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.042 0.448 . . . . 0.0 111.252 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' OH ' ' HA ' ' A' ' 65' ' ' LEU . 73.2 m-85 -92.61 -14.09 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -93.61 -176.84 4.2 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.958 0.903 . . . . 0.0 111.389 178.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 t -91.78 149.53 39.26 Favored Pre-proline 0 N--CA 1.425 -1.681 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.87 174.25 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.63 2.22 . . . . 0.0 111.657 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.98 -28.78 37.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.729 0.776 . . . . 0.0 110.142 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -75.88 105.89 7.17 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 t30 68.24 80.08 0.21 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.247 1.019 . . . . 0.0 109.162 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 82' ' ' ALA . 60.1 tp -113.67 172.88 6.71 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.844 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -143.73 101.99 3.85 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.186 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.83 46.42 3.65 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.35 156.21 23.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.905 0.882 . . . . 0.0 109.26 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.37 119.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 28.4 m -111.54 137.83 48.86 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.756 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HG2' ' A' ' 11' ' ' LYS . 9.0 t -116.59 123.07 46.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.716 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.2 mtm -101.43 143.25 31.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -84.2 142.96 29.93 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.487 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.34 136.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 34.2 mt -98.14 115.14 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.416 HG23 ' HD3' ' A' ' 50' ' ' PRO . 1.7 mp -90.11 104.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.631 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 91' ' ' ILE . 53.0 mt-30 -115.25 111.06 20.37 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -74.6 152.99 87.49 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.026 -174.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 17.3 Cg_exo -70.39 -156.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.694 2.929 . . . . 0.0 110.219 173.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.56 -31.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 8.3 t -70.64 92.85 0.88 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 172.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.67 107.71 1.34 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' HG2' ' A' ' 100' ' ' GLU . 88.0 tttt -142.66 174.29 10.77 Favored 'General case' 0 N--CA 1.408 -2.541 0 O-C-N 123.416 0.448 . . . . 0.0 110.217 -167.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.565 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 12.1 pt-20 -35.11 -42.59 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.902 2.081 . . . . 0.0 115.746 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 C--N 1.309 -1.186 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.749 -179.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.97 107.68 2.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -126.32 96.95 4.87 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.95 142.66 42.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -96.18 79.02 3.14 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.061 0.934 . . . . 0.0 110.188 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -170.74 -48.15 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.627 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 79.0 mt-30 -100.0 164.07 12.16 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.42 138.29 44.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 1.6 mp0 -88.37 142.69 27.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.977 0.894 . . . . 0.0 112.843 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 72.5 mt -126.77 137.57 57.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.915 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -119.8 144.24 47.42 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -104.22 122.57 45.65 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASP . 56.7 ttt180 -117.76 117.68 29.99 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.519 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.36 154.52 41.91 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.18 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -60.48 -16.56 37.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 111.217 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.65 -6.45 53.89 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.017 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.59 3.37 64.62 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.2 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -102.8 140.81 36.59 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.1 p-10 -117.9 162.3 18.35 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.527 0.679 . . . . 0.0 110.918 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.34 140.45 24.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.9 140.3 34.93 Favored Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.834 0.708 . . . . 0.0 112.065 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.85 137.82 50.74 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.184 1.922 . . . . 0.0 112.452 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.8 tttp -122.15 153.04 39.27 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -89.82 128.97 36.26 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.231 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.6 m-85 -128.71 133.55 25.31 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -67.85 148.71 77.34 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.124 1.882 . . . . 0.0 110.638 172.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 22.1 m-20 -68.87 -23.98 64.29 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 111.096 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.9 -5.83 56.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 71' ' ' VAL . 95.5 m -77.44 137.38 38.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 44.5 p -81.05 156.67 25.73 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.567 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HD12 ' A' ' 65' ' ' LEU . 62.1 t -60.56 -30.12 46.07 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.728 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -58.27 -44.76 88.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.965 0.412 . . . . 0.0 110.447 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -77.61 -22.21 51.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.9 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' VAL . 34.8 tp -67.7 -44.65 77.21 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' LEU . 59.6 mtpt -72.13 -32.7 67.17 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.896 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -64.12 -35.61 81.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.087 0.946 . . . . 0.0 109.425 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.9 m -66.75 -37.76 85.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.62 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 56' ' ' VAL . 59.7 t -59.23 -39.58 79.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 51' ' ' LYS . 33.1 mt -57.77 -42.41 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.893 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -75.16 -24.28 57.88 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -91.34 -15.68 28.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.675 0.274 . . . . 0.0 111.649 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -77.19 138.34 64.6 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -45.83 114.69 0.83 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.696 2.93 . . . . 0.0 113.647 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.84 -25.66 67.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.551 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.22 -28.04 64.95 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.057 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.86 82.31 7.85 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.5 148.94 30.23 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 71.7 14.54 6.08 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.487 0.715 . . . . 0.0 111.447 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.68 176.46 23.09 Favored Glycine 0 N--CA 1.417 -2.586 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -69.22 58.5 1.3 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 124.096 3.197 . . . . 0.0 113.788 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 39' ' ' ILE . 53.2 mtmt -84.36 -48.22 9.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -78.45 160.78 27.54 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.87 -28.52 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.802 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -71.19 -32.88 69.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.53 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 4.8 mm-40 -98.4 -14.23 20.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -168.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 38' ' ' VAL . 42.7 t -94.9 129.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.564 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 97.8 mttt -112.67 119.64 38.8 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 35' ' ' LYS . 2.8 mm? -99.91 121.97 42.13 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 91' ' ' ILE . 1.7 mp -110.78 122.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 122.714 0.406 . . . . 0.0 109.939 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -130.8 130.92 44.29 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.8 14.9 9.56 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.443 0.697 . . . . 0.0 111.604 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.59 9.75 61.1 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.883 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -134.22 139.97 46.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.57 133.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.487 HD12 HG22 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -95.93 125.45 40.49 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.452 0.644 . . . . 0.0 112.403 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 68' ' ' SER . 37.0 tt0 -83.28 150.06 26.39 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.215 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.72 -30.37 22.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.16 1.384 . . . . 0.0 112.593 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.449 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 17.9 m -78.87 -7.78 58.23 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.21 167.27 10.97 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 122.36 0.264 . . . . 0.0 110.976 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -105.92 167.54 9.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 29' ' ' THR . 90.8 t -71.26 -34.11 53.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.529 0.68 . . . . 0.0 109.681 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 85.3 tttt -58.15 -33.51 69.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.503 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.85 -38.33 67.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.45 0.7 . . . . 0.0 112.05 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 44.8 m-85 -94.01 -14.03 26.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -76.39 162.62 27.72 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -72.29 146.1 88.96 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.89 170.76 0.41 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 123.38 2.72 . . . . 0.0 112.95 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.51 76.18 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 110.967 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -160.31 26.6 0.16 Allowed 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -142.74 157.46 44.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.3 mt -63.42 148.06 49.55 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-O 120.986 0.422 . . . . 0.0 109.868 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.72 72.75 10.14 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.624 0.726 . . . . 0.0 110.792 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.86 47.8 0.08 OUTLIER Glycine 0 C--N 1.297 -1.616 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.48 117.58 29.82 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.54 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 64.7 t -86.09 137.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 m -123.84 127.94 48.78 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.757 0.313 . . . . 0.0 111.048 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.5 m -97.96 118.64 34.99 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.8 mtt -105.14 135.54 46.3 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -90.89 123.66 34.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.392 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.86 123.0 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.836 0.827 . . . . 0.0 110.399 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 37.0 mm -97.56 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.553 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.057 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.431 HG23 ' HG2' ' A' ' 50' ' ' PRO . 48.4 mm -88.32 116.16 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.487 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -116.35 111.3 19.88 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.61 122.63 71.69 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.326 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' HG3' ' HG3' ' A' ' 55' ' ' GLU . 78.4 Cg_exo -48.89 152.65 4.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.191 3.261 . . . . 0.0 113.443 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.1 -53.27 17.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 t -154.3 109.53 3.13 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.655 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -88.13 92.8 9.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -171.26 95.04 0.18 Allowed 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.82 -63.74 1.08 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.423 -172.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.206 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.93 83.85 1.65 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.997 0.427 . . . . 0.0 110.926 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.75 89.66 6.73 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.632 0.73 . . . . 0.0 111.158 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.91 128.21 54.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 8.1 p80 -129.72 82.22 2.06 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -105.36 -26.97 11.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 18.5 mp0 -99.02 -171.49 2.1 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 4.6 mp -94.24 130.9 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.483 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 39.7 mt-10 -91.66 125.04 36.25 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.439 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 74.5 mt -107.59 126.06 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-O 121.384 0.611 . . . . 0.0 109.899 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' PRO . 14.2 ptmm? -120.37 135.78 54.92 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.328 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -93.26 122.31 35.52 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -119.36 128.06 53.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.379 0.609 . . . . 0.0 110.625 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 92' ' ' ILE . 76.2 mt -81.99 168.19 18.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.829 -177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -67.59 -18.55 65.03 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.605 0.717 . . . . 0.0 111.481 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.79 -7.38 59.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.913 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.28 72.82 Favored Glycine 0 CA--C 1.506 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.976 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -83.46 135.17 34.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -122.3 157.16 32.34 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.473 0.654 . . . . 0.0 111.897 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.3 140.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.52 133.6 25.71 Favored Glycine 0 C--O 1.243 0.664 0 O-C-N 124.128 0.892 . . . . 0.0 113.841 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 18.6 Cg_endo -68.79 145.54 63.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.631 2.887 . . . . 0.0 114.162 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 12.6 mptt -125.6 163.21 23.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.92 123.25 34.28 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.413 0.446 . . . . 0.0 109.915 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 49.6 m-85 -128.54 129.19 23.55 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -57.8 148.97 72.01 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.911 1.741 . . . . 0.0 110.43 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.26 -22.96 66.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.375 0.607 . . . . 0.0 109.801 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.63 5.74 14.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.767 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.1 m -66.7 135.65 54.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.672 0.273 . . . . 0.0 110.419 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 4.8 t -84.09 144.87 28.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.054 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 69' ' ' LYS . 61.5 t -60.27 -26.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 50.4 m -54.86 -46.43 74.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.667 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.0 50.19 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.088 0.471 . . . . 0.0 110.57 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 38' ' ' VAL . 54.1 tp -68.52 -42.25 78.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . 72.0 mmtt -61.11 -43.87 98.21 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.135 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.4 mm-40 -56.92 -41.69 78.63 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.365 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.48 -39.58 85.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.108 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 34' ' ' LEU . 47.9 t -59.19 -53.15 52.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.606 0.762 . . . . 0.0 110.583 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 51' ' ' LYS . 36.6 mt -63.13 -35.22 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 m -76.04 -39.19 56.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.355 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -80.68 -25.77 37.99 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -70.59 126.39 92.22 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -37.9 121.41 0.45 Allowed 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.204 3.27 . . . . 0.0 113.735 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -66.14 -23.92 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.725 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -67.96 -24.67 65.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.613 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -83.33 87.71 6.96 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.39 151.06 25.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.66 20.03 10.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.338 1.066 . . . . 0.0 110.014 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.19 175.75 23.11 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.99 84.82 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.272 1.981 . . . . 0.0 110.869 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' O ' HG12 ' A' ' 39' ' ' ILE . 61.2 tttm -124.12 -28.4 3.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.292 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -93.86 172.13 8.43 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.5 t -53.41 -45.64 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.623 1.169 . . . . 0.0 113.728 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 1.6 mppt? -77.36 -29.6 53.4 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.582 -173.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.54 -32.49 25.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.499 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 38' ' ' VAL . 48.6 t -94.89 116.45 36.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 98.6 mttt -101.83 127.55 48.59 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 65' ' ' LEU . 1.1 tm? -101.54 122.53 44.0 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -175.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mm -115.17 124.92 72.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 123.561 0.744 . . . . 0.0 112.499 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 79.7 p -124.46 118.3 26.34 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.96 16.17 9.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.139 0.976 . . . . 0.0 111.793 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.7 0.81 58.98 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.523 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -106.01 138.1 42.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.5 127.11 38.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.612 HD12 HD12 ' A' ' 58' ' ' LEU . 44.7 mt -76.97 110.95 12.01 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.8 133.53 40.63 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.603 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' SER . 57.5 t30 -51.82 -35.0 42.81 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -172.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -91.04 5.92 46.94 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 17.1 ptpt -120.1 166.49 13.33 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.653 -0.654 . . . . 0.0 111.35 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 81.4 p -99.68 166.68 11.0 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.38 -33.51 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.545 0.688 . . . . 0.0 109.621 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 13.4 tmtt? -56.69 -32.91 65.92 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 124.942 1.297 . . . . 0.0 111.421 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.14 -37.99 87.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 110.304 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -87.7 -27.34 22.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.809 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -76.94 102.98 6.63 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-O 121.282 0.563 . . . . 0.0 110.721 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 m -100.52 144.88 29.33 Favored Pre-proline 0 C--N 1.292 -1.918 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.318 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.83 112.1 3.43 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.912 1.741 . . . . 0.0 112.16 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.39 -16.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 122.35 1.071 . . . . 0.0 108.84 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 p -161.3 111.28 1.65 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.435 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -78.18 93.58 4.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.677 0.751 . . . . 0.0 111.775 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.4 mt -96.96 178.02 5.42 Favored 'General case' 0 N--CA 1.387 -3.596 0 C-N-CA 124.499 1.12 . . . . 0.0 109.079 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.26 96.41 3.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . 81.56 75.55 1.11 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.454 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' LEU . . . -97.67 153.75 18.02 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 122.413 0.285 . . . . 0.0 110.637 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -102.14 130.2 52.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.2 m -123.31 127.87 49.14 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.208 0.528 . . . . 0.0 110.677 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.5 m -96.82 118.72 33.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 24.4 mmt -100.24 136.69 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -93.56 123.79 37.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.78 122.81 48.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.251 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 36.5 mm -98.97 119.1 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.979 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 14' ' ' LEU . 2.0 mp -100.06 109.21 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.218 -176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.39 113.2 26.07 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.83 118.51 42.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.292 -170.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.64 146.02 88.04 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.132 2.555 . . . . 0.0 110.198 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.2 123.12 56.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.303 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.4 m -156.68 122.28 4.78 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -102.89 107.3 18.08 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.151 0.5 . . . . 0.0 110.801 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -155.83 140.47 16.96 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -151.42 85.01 1.31 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.194 0.997 . . . . 0.0 110.764 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.296 -1.76 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.7 102.03 3.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.346 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 66.89 114.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.671 1.188 . . . . 0.0 112.302 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.93 136.31 53.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -101.3 116.69 33.39 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.32 124.62 33.56 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.948 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -80.02 -153.15 0.08 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.3 116.9 29.37 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.88 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 35.7 mt-10 -91.22 127.43 36.64 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.012 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 59.3 mt -125.39 139.02 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.809 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -118.45 152.57 35.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -109.47 117.72 34.73 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.417 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 19' ' ' ASP . 34.2 ttm180 -116.18 118.48 32.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.292 0.567 . . . . 0.0 110.499 173.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 4.8 mp -68.33 152.18 45.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -65.19 -13.79 59.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 122.346 1.07 . . . . 0.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.14 -3.32 44.93 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.212 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.0 5.66 60.78 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.98 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.4 p -108.17 142.93 37.66 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 117.315 0.558 . . . . 0.0 110.345 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' HE ' ' A' ' 13' ' ' ARG . 4.6 p-10 -129.39 151.44 50.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.83 0.824 . . . . 0.0 113.22 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.25 140.52 24.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.36 155.21 18.55 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 123.726 0.641 . . . . 0.0 114.083 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.08 145.61 73.97 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 123.163 2.576 . . . . 0.0 113.053 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 11.8 tmtt? -136.17 149.37 48.59 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.6 122.25 32.57 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 118.388 0.54 . . . . 0.0 111.218 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 73.1 m-85 -113.54 117.33 45.02 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.5 149.85 87.87 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.665 2.243 . . . . 0.0 112.165 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.48 -29.44 61.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.35 -7.74 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.711 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.9 m -75.98 133.8 40.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.856 0.36 . . . . 0.0 110.668 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 p -80.96 158.16 25.3 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.341 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 92.0 t -65.48 -25.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 21.0 t -60.15 -49.48 77.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.42 63.32 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.202 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 68.5 tp -65.42 -43.27 91.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' O ' HG13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -69.35 -34.92 75.33 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.184 174.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 32' ' ' SER . 42.3 mm-40 -56.46 -36.94 69.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.4 m -63.39 -43.87 96.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.768 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.61 -50.35 78.5 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.512 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 35' ' ' LYS . 70.4 mt -55.21 -35.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.986 0.914 . . . . 0.0 111.053 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 m -69.81 -39.63 76.42 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -82.93 -39.54 21.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 122.963 0.505 . . . . 0.0 111.626 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 63.1 t-105 -66.47 135.97 94.84 Favored Pre-proline 0 C--N 1.31 -1.13 0 C-N-CA 123.749 0.819 . . . . 0.0 110.929 -174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.18 119.16 5.68 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.283 2.655 . . . . 0.0 113.298 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -63.92 -22.74 67.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.31 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.24 -11.47 59.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.744 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -71.98 109.99 6.17 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 101' ' ' LYS . 42.0 mm-40 -73.76 136.92 43.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 48' ' ' ASN . 12.9 m120 52.42 81.73 0.08 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.378 1.049 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.23 -170.29 41.86 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.151 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 56' ' ' VAL . 50.2 Cg_exo -55.5 43.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.522 3.184 1 C-N-CA 126.648 4.899 . . . . 0.0 116.274 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 51' ' ' LYS . 4.3 tmmm? -80.83 -29.42 35.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.2 p -130.93 172.57 11.9 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.731 0.777 . . . . 0.0 112.914 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -56.81 -28.05 27.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 126.65 1.98 . . . . 0.0 113.503 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.46 -26.56 51.54 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.303 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.45 -6.65 58.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.652 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 50' ' ' PRO . 38.2 t -111.84 116.82 53.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.47 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.06 140.81 48.75 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 2.6 mm? -113.56 128.31 56.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.159 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -117.72 124.67 73.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.508 ' HB2' ' SD ' ' A' ' 88' ' ' MET . 45.7 t -128.86 124.0 34.16 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.64 22.37 10.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.105 0.962 . . . . 0.0 111.491 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.51 23.45 58.34 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.446 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 64' ' ' VAL . 10.5 tmtt? -135.68 131.61 35.9 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 10.3 p -88.89 130.88 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.193 0.52 . . . . 0.0 111.226 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -102.1 134.91 44.59 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 160.59 14.41 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.444 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 5.4 p30 -59.19 -21.64 59.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -168.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.1 m -67.89 -30.77 70.19 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -95.16 167.21 11.51 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.8 p -101.73 172.19 7.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 123.171 0.588 . . . . 0.0 111.661 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.64 -26.69 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 tttt -55.43 -32.97 63.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.919 1.288 . . . . 0.0 111.016 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.12 -35.07 78.95 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.963 0.411 . . . . 0.0 111.848 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -106.75 5.51 28.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' LYS . 36.0 ptt180 -71.54 153.31 42.26 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.128 0.49 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.1 m -76.87 171.78 11.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.85 176.41 3.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.981 1.788 . . . . 0.0 111.873 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.63 -24.61 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.749 0.785 . . . . 0.0 111.201 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -93.33 100.49 12.82 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -152.11 -172.25 4.17 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.48 178.27 6.07 Favored 'General case' 0 N--CA 1.396 -3.145 0 C-N-CA 123.378 0.671 . . . . 0.0 111.655 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.69 102.45 4.75 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.82 48.9 2.21 Favored Glycine 0 C--N 1.291 -1.917 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.32 129.61 55.52 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.34 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.8 t -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.524 0.678 . . . . 0.0 110.076 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 76.2 m -98.42 128.57 44.85 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.6 m -96.31 117.83 31.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 52.8 tpp -102.44 140.12 37.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -96.15 123.86 39.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 14' ' ' LEU . 44.5 t -97.78 120.93 47.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.916 0.865 . . . . 0.0 110.508 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -103.17 118.03 49.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.248 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.49 123.14 45.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.967 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLN . 13.1 mm-40 -113.12 111.18 21.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.75 126.99 90.39 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.257 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.414 ' HG2' ' OE1' ' A' ' 98' ' ' GLU . 33.5 Cg_exo -60.63 139.44 85.82 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.513 2.142 . . . . 0.0 110.309 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.31 -32.99 60.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.026 0.441 . . . . 0.0 110.734 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -138.13 143.26 40.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 95' ' ' PRO . 31.9 tt0 -168.01 -59.88 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 176.79 -71.76 0.01 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.523 1.129 . . . . 0.0 108.857 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.72 95.62 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' H ' ' HG3' ' A' ' 47' ' ' GLU . 29.0 tptp . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.239 0.526 0 CA-C-O 120.637 0.255 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.51 93.69 0.85 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.23 138.87 42.21 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.541 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.06 -31.54 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 122.184 0.992 . . . . 0.0 110.077 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 65.07 3.63 2.23 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.4 1.88 . . . . 0.0 113.851 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -97.98 -37.21 9.87 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' HA2' ' A' ' 83' ' ' GLY . 1.7 mp0 -95.28 -170.82 2.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 171.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.1 pt? -102.66 132.43 48.78 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.715 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.9 mp0 -90.03 140.55 29.53 Favored 'General case' 0 N--CA 1.422 -1.853 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.708 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 77.7 mt -128.09 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.476 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -119.08 151.05 38.96 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 90' ' ' VAL . 65.5 m-85 -106.92 117.8 35.01 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.04 125.78 54.38 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.295 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 90' ' ' VAL . 83.8 mt -76.75 168.71 19.62 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.313 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.5 t -72.34 -13.73 61.56 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.446 1.117 . . . . 0.0 108.587 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.27 -8.46 58.4 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.826 -1.533 . . . . 0.0 110.574 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.13 2.98 87.82 Favored Glycine 0 CA--C 1.509 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.206 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 m -99.73 130.15 45.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.42 162.72 18.35 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.031 0.443 . . . . 0.0 112.051 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.04 141.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.774 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.44 20.72 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 124.105 0.878 . . . . 0.0 112.792 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.09 145.78 68.29 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.209 2.606 . . . . 0.0 114.499 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 60.1 mtpt -131.63 163.22 28.58 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.84 124.98 38.2 Favored 'General case' 0 C--N 1.264 -3.131 0 O-C-N 124.004 0.815 . . . . 0.0 110.997 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 62.3 m-85 -126.75 117.63 22.54 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.37 148.6 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.812 1.675 . . . . 0.0 111.467 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.21 -27.67 69.15 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.499 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.0 -1.47 48.38 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -78.65 144.31 35.53 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.937 0.398 . . . . 0.0 111.986 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.1 p -72.41 151.22 42.75 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 112.553 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 65' ' ' LEU . 77.4 t -68.89 -27.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.797 175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.513 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 9.9 p -60.13 -49.05 79.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.32 -31.32 72.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.411 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 62.0 tp -63.98 -47.6 79.71 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 123.777 0.831 . . . . 0.0 109.771 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 39' ' ' ILE . 41.2 ttmt -69.32 -42.17 75.73 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.389 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 32' ' ' SER . 47.9 mm-40 -56.28 -31.71 63.88 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.737 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.61 -44.41 86.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -47.4 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 51' ' ' LYS . 41.2 mt -58.09 -39.81 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.377 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -75.39 -35.74 61.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.109 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -79.71 -12.58 59.8 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' A' ' 51' ' ' LYS . 29.8 t-105 -71.65 133.21 84.77 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HB2' ' CG ' ' A' ' 46' ' ' LYS . 71.9 Cg_exo -50.41 120.15 5.97 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.553 2.168 . . . . 0.0 112.051 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -62.86 -41.42 99.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.648 -175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.88 -25.64 67.98 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.679 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 43' ' ' PRO . 67.0 mmtt -60.52 165.13 3.93 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.72 162.34 0.26 Allowed 'General case' 0 C--O 1.262 1.76 0 CA-C-N 113.561 -1.654 . . . . 0.0 113.137 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -82.06 70.82 9.07 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 50' ' ' PRO . . . -120.91 -119.72 2.69 Favored Glycine 0 N--CA 1.413 -2.896 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.061 -176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 92' ' ' ILE . 17.1 Cg_exo -71.6 52.39 1.64 Allowed 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.826 3.017 . . . . 0.0 115.076 -176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' O ' HG12 ' A' ' 39' ' ' ILE . 51.3 mttp -96.58 -65.95 0.94 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.342 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.6 p -77.65 170.48 16.5 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -168.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.6 -41.88 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.94 1.696 . . . . 0.0 115.081 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.86 -16.78 58.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -95.42 -9.69 32.0 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.964 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.89 127.09 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.461 0.648 . . . . 0.0 112.55 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 58.3 mtpt -111.3 139.15 46.94 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -112.62 122.16 46.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 91' ' ' ILE . 51.1 mt -124.18 133.84 68.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.333 0.587 . . . . 0.0 110.648 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' MET . 22.9 t -143.04 130.83 21.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.43 17.9 10.75 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.712 0.805 . . . . 0.0 111.354 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.87 12.8 70.81 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.765 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.56 138.83 51.66 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.23 121.15 36.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 7.0 mp -78.63 121.66 24.95 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 112.433 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 36.0 tt0 -74.28 133.51 42.61 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.732 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -67.5 -21.66 65.49 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.274 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.9 m -80.31 -6.05 57.31 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 18.3 ptpt -108.13 167.73 9.8 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 23.7 p -99.49 172.51 7.27 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 122.784 0.434 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.11 -25.89 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -53.81 -33.7 56.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.937 1.695 . . . . 0.0 111.094 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.4 -30.02 71.22 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.915 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 97.9 m-85 -108.52 5.16 24.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.683 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -78.94 138.69 38.2 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -114.06 138.71 22.99 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.97 112.94 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.079 1.853 . . . . 0.0 110.895 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.03 -21.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m 66.29 20.78 11.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.398 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -166.6 169.73 13.35 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.44 154.36 42.14 Favored 'General case' 0 N--CA 1.387 -3.58 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.92 80.27 1.57 Allowed 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.098 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 7' ' ' GLN . . . -104.17 54.06 0.67 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.1 154.41 19.01 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -84.36 119.49 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -96.67 137.32 35.92 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.0 m -103.15 118.28 36.44 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.637 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -98.3 142.13 30.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.834 176.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -94.82 123.88 38.54 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 12' ' ' PHE . 75.2 t -101.41 120.86 51.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.882 0.848 . . . . 0.0 110.299 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 35.2 mm -98.89 116.58 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 50' ' ' PRO . 46.3 mm -100.08 119.61 48.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.517 -175.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -116.77 109.02 16.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.66 145.78 31.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.059 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.27 163.36 32.23 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.189 1.926 . . . . 0.0 109.852 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.6 t -73.0 95.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.211 0.529 . . . . 0.0 109.973 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.4 t -170.76 148.7 2.98 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.72 118.85 15.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 69.48 76.05 0.23 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 124.026 0.829 . . . . 0.0 111.25 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.7 76.91 1.09 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.1 116.91 21.41 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -152.7 109.08 3.4 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 120.978 0.418 . . . . 0.0 110.17 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.99 -33.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 122.231 1.015 . . . . 0.0 109.359 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.25 3.5 p-80 -85.42 83.72 7.86 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 122.681 1.229 . . . . 0.0 109.692 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.6 142.98 43.22 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.292 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.46 -147.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 75' ' ' ARG . 5.1 mp -97.33 123.58 41.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.503 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 42.4 mt-10 -91.4 120.24 32.08 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 62.3 mt -107.91 129.37 62.15 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.049 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.05 137.53 52.19 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.609 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.451 ' HB3' HG21 ' A' ' 90' ' ' VAL . 94.8 m-85 -93.73 119.36 32.61 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.046 -174.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -98.39 115.13 27.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.638 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.71 169.83 14.86 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -67.21 -22.95 65.69 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.474 0.71 . . . . 0.0 112.386 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.86 -3.01 58.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.662 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.12 9.84 79.41 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -83.14 156.53 23.21 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 5.1 p-10 -133.18 158.22 43.39 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.064 0.459 . . . . 0.0 110.507 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.8 mt -106.25 140.09 25.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.24 130.87 33.6 Favored Glycine 0 C--O 1.239 0.463 0 O-C-N 124.199 0.937 . . . . 0.0 112.416 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.81 140.64 94.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.62 2.213 . . . . 0.0 112.137 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 23.4 ttmm -128.03 154.68 45.39 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.3 123.11 33.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.21 0.529 . . . . 0.0 110.843 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 58.0 m-85 -124.28 117.32 26.79 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 73.1 Cg_exo -59.16 150.16 75.58 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.921 2.414 . . . . 0.0 112.276 171.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.71 -33.76 35.76 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.636 0.731 . . . . 0.0 110.309 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.23 34.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.135 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 71' ' ' VAL . 83.6 m -76.12 135.63 39.83 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.136 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 29.1 p -81.22 153.55 27.11 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.009 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.55 -26.27 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.059 0.457 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -57.66 -49.3 76.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.51 -31.3 69.45 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.779 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' VAL . 50.7 tp -64.22 -49.3 72.5 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -59.29 -46.79 87.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.232 1.013 . . . . 0.0 110.746 178.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -56.93 -39.77 75.14 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.445 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 99.9 m -67.65 -40.35 84.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.904 176.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 34' ' ' LEU . 63.4 t -58.72 -51.38 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 51' ' ' LYS . 62.8 mt -61.17 -33.43 56.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -75.96 -39.34 56.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' THR . 16.2 mm-40 -76.81 -28.61 55.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.001 0.429 . . . . 0.0 110.639 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -76.07 135.07 70.48 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 22.3 Cg_exo -62.23 109.1 0.77 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.415 1.41 . . . . 0.0 111.724 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.01 -23.6 64.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.78 0.8 . . . . 0.0 108.927 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.57 -10.45 59.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.511 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 22.2 tptm -70.85 158.31 36.6 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.59 -174.82 0.1 Allowed 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 123.952 0.901 . . . . 0.0 111.28 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' HB2' ' HA ' ' A' ' 97' ' ' THR 0.291 3.7 m-20 -73.56 71.81 1.38 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.779 1.276 . . . . 0.0 114.3 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.3 -146.18 12.72 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 105.83 -2.908 . . . . 0.0 105.83 167.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CG ' HG23 ' A' ' 92' ' ' ILE . 31.7 Cg_exo -65.93 139.55 57.12 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 N-CA-C 107.983 -1.584 . . . . 0.0 107.983 168.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' ILE . 40.7 ttmt -149.52 -39.55 0.15 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.619 177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.8 p -118.69 171.84 7.92 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.366 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 8.1 p -54.54 -26.37 16.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 C-N-CA 125.372 1.469 . . . . 0.0 112.776 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 96.0 mttt -69.63 -20.9 63.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 122.213 -0.305 . . . . 0.0 110.231 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 54' ' ' LYS . 3.1 mp0 -105.08 -50.15 3.31 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.379 178.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.5 114.68 31.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.744 0.783 . . . . 0.0 112.087 -175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -117.76 146.21 43.96 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.946 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 1.8 mm? -101.78 124.3 47.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.113 -176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mt -129.14 129.72 67.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.393 0.616 . . . . 0.0 111.947 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -124.57 119.76 29.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.24 20.39 11.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.038 0.935 . . . . 0.0 112.623 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.49 48.1 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.712 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -129.69 124.57 33.89 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -83.85 137.04 21.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.534 0.683 . . . . 0.0 111.745 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' ' CE2' ' A' ' 74' ' ' TYR . 5.8 mp -92.98 108.38 19.96 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.005 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.71 158.51 15.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.78 -22.82 15.45 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -173.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -74.48 -15.17 60.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.145 0.498 . . . . 0.0 112.237 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -95.01 166.65 11.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.3 m -118.39 165.09 14.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' THR . 92.8 t -66.37 -36.59 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.391 0.615 . . . . 0.0 109.737 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.42 -33.6 54.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.387 1.075 . . . . 0.0 112.155 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.83 -41.23 95.39 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.353 0.597 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 80.3 m-85 -95.97 5.14 51.91 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.754 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HD3' HD21 ' A' ' 8' ' ' LEU . 15.9 tpt180 -81.09 99.79 8.69 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 38.8 m -80.62 141.34 52.08 Favored Pre-proline 0 C--N 1.29 -1.985 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.903 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 76' ' ' SER . 7.4 Cg_exo -70.7 115.18 4.11 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.988 1.792 . . . . 0.0 110.334 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 80.6 t -151.48 143.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -40.21 113.52 0.36 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 124.884 1.365 . . . . 0.0 111.323 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -88.77 107.15 18.81 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.436 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.25 -179.15 4.69 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.831 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.12 82.13 7.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.719 0.771 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.67 99.44 1.7 Allowed Glycine 0 C--N 1.295 -1.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.071 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.25 130.01 56.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.91 129.06 68.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 34.6 m -122.8 122.51 38.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.553 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.6 m -96.5 124.75 40.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 58' ' ' LEU . 44.1 ttp -117.09 141.88 47.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 120.659 0.266 . . . . 0.0 110.693 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -83.63 130.51 34.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.749 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 12' ' ' PHE . 60.8 t -102.48 135.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.5 mm -98.25 116.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.381 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.408 HG23 ' CG ' ' A' ' 50' ' ' PRO . 2.2 mp -100.66 105.88 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.082 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -97.75 111.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.56 114.61 65.15 Favored Pre-proline 0 C--N 1.287 -2.133 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.35 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -91.61 -178.45 1.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.678 2.252 . . . . 0.0 110.727 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.53 139.21 18.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASN . 53.7 m -69.51 119.78 14.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.01 120.34 10.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.3 tttt 70.19 168.54 0.3 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.339 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 70.28 9.38 6.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.136 0.974 . . . . 0.0 111.798 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.773 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.13 123.43 34.41 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.978 0.418 . . . . 0.0 111.18 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.33 161.73 37.65 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.253 1.021 . . . . 0.0 108.581 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.475 ' CG2' HD22 ' A' ' 6' ' ' ASN . 11.8 p -83.42 151.33 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.844 -175.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -99.48 10.25 41.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.475 HD22 ' CG2' ' A' ' 4' ' ' VAL . 54.4 m-80 -85.17 -12.31 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.456 0.646 . . . . 0.0 109.786 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 94.3 mt-30 -95.67 165.47 12.3 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.22 139.11 39.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.319 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 5.1 mp0 -89.28 135.09 33.77 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.142 0.972 . . . . 0.0 111.725 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 50.2 mt -124.55 139.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.201 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.62 144.44 44.39 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -102.57 126.1 49.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.651 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -98.01 119.79 37.26 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 92' ' ' ILE . 2.8 mm? -82.23 164.67 21.04 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -69.39 -16.76 63.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.482 0.658 . . . . 0.0 111.32 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.41 -8.88 58.98 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.66 3.27 74.59 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.038 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 p -99.91 155.11 17.86 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.34 169.02 12.74 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.305 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.444 HG13 HD21 ' A' ' 14' ' ' LEU . 57.6 mt -105.95 140.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.16 143.5 33.89 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 23.6 Cg_endo -58.02 141.38 96.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.41 2.073 . . . . 0.0 112.907 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 50.7 tptt -121.24 149.99 42.02 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 7' ' ' GLN . . . -93.82 126.14 38.85 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 118.84 0.745 . . . . 0.0 111.409 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.6 m-85 -129.85 126.63 22.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.114 0.566 . . . . 0.0 110.253 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 29' ' ' THR . 41.4 Cg_exo -62.71 151.09 85.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 123.422 2.748 . . . . 0.0 112.701 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 72' ' ' LYS . 4.9 m-20 -50.05 -37.27 32.58 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.897 0.879 . . . . 0.0 112.491 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.73 -6.25 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 26' ' ' PRO . 88.9 m -64.87 135.55 55.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.722 0.296 . . . . 0.0 110.974 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 57.2 p -83.63 159.21 21.63 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.661 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 98.5 t -63.56 -30.69 50.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.288 0.635 . . . . 0.0 109.936 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.2 t -61.58 -42.06 98.31 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.09 71.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.264 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 mm? -56.07 -50.28 71.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.3 mttt -66.01 -41.28 91.23 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.667 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 32' ' ' SER . 15.1 mm-40 -56.55 -40.32 74.95 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 92.5 m -63.86 -46.86 83.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 34' ' ' LEU . 100.0 t -57.62 -48.28 83.6 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 35' ' ' LYS . 61.9 mt -60.29 -38.06 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -76.03 -40.8 52.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' THR . 17.0 mm-40 -77.92 -29.32 50.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.055 0.455 . . . . 0.0 111.562 -175.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t-105 -72.14 148.41 91.42 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 42' ' ' TRP . 18.6 Cg_exo -37.03 140.89 0.17 Allowed 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 124.443 3.429 . . . . 0.0 115.483 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -33.68 74.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.221 0.534 . . . . 0.0 110.135 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -85.23 4.06 36.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.246 1.018 . . . . 0.0 111.105 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -35.52 138.0 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -169.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 49' ' ' GLY . 12.8 pt-20 -77.51 -163.36 0.38 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.988 1.715 . . . . 0.0 112.052 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.44 HD21 ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-20 -63.53 14.49 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.511 1.524 . . . . 0.0 114.059 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 47' ' ' GLU . . . -96.84 -136.67 9.12 Favored Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HG3' HG13 ' A' ' 92' ' ' ILE . 86.6 Cg_exo -57.39 99.9 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.024 2.483 . . . . 0.0 111.486 173.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -119.26 -47.03 2.48 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.161 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 p -133.09 174.34 10.47 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.844 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 9.5 p -59.66 -27.43 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 124.053 0.941 . . . . 0.0 110.946 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.78 -16.6 63.33 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.797 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . 0.272 1.0 OUTLIER -124.81 19.79 8.51 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 7.7 p -120.91 120.69 63.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.138 0.494 . . . . 0.0 109.895 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 40.3 ttmt -115.18 142.86 46.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.696 HD11 ' SD ' ' A' ' 88' ' ' MET . 1.8 tm? -120.46 123.17 42.32 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.26 132.26 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 122.889 0.476 . . . . 0.0 110.22 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 88' ' ' MET . 22.8 t -135.01 130.67 36.07 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.98 20.24 11.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.702 0.801 . . . . 0.0 111.74 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 21.88 53.77 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.417 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.6 140.48 50.43 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.82 128.31 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.2 mp -89.82 114.81 26.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 120.957 0.408 . . . . 0.0 111.944 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 130.43 40.87 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 77.5 m-20 -46.6 -35.85 6.3 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.407 1.483 . . . . 0.0 114.57 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -69.72 -23.67 63.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -78.82 166.01 22.91 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.193 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 39.9 p -105.22 167.85 9.45 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 123.225 0.61 . . . . 0.0 111.704 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.79 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 61.1 tttm -55.89 -33.51 64.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.482 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.36 -36.8 84.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.116 0.484 . . . . 0.0 111.564 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.4 -18.15 18.43 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.263 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.8 ttp85 -77.24 157.48 30.8 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.561 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 m -67.38 146.86 98.88 Favored Pre-proline 0 N--CA 1.426 -1.653 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.76 -179.55 1.34 Allowed 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.271 1.981 . . . . 0.0 112.355 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.86 83.44 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 122.592 1.187 . . . . 0.0 110.642 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -109.51 176.75 4.96 Favored 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 113.233 -1.803 . . . . 0.0 107.114 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -90.59 93.82 9.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.828 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -101.36 -175.97 3.01 Favored 'General case' 0 N--CA 1.381 -3.884 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.022 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.23 93.14 3.59 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 120.96 0.41 . . . . 0.0 111.253 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.43 94.75 0.27 Allowed Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.64 102.81 11.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.164 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.22 125.79 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.553 ' HB ' HG12 ' A' ' 10' ' ' ILE . 23.7 m -100.15 134.02 43.7 Favored 'General case' 0 C--N 1.275 -2.654 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.937 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.4 m -106.0 118.54 36.88 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 58' ' ' LEU . 61.9 mtt -121.09 138.9 53.97 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.162 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -98.43 123.87 42.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -97.29 122.4 48.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.154 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 53.6 mt -99.36 121.4 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.051 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.681 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.508 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.7 mp -87.91 122.94 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.532 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -101.92 111.21 23.39 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.54 115.72 46.36 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.479 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.96 -177.89 3.97 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.397 2.065 . . . . 0.0 111.766 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.42 135.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.2 m -73.37 86.02 1.48 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.342 1.068 . . . . 0.0 111.842 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.28 88.22 1.22 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' ASN 0.272 62.0 pttt -89.25 73.93 7.99 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -172.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.97 89.07 7.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? . . . . . 0 N--CA 1.409 -2.484 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -173.326 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.84 110.59 21.81 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.33 99.49 5.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 121.224 0.535 . . . . 0.0 111.816 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.75 2.58 10.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.475 1.131 . . . . 0.0 109.011 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.86 88.7 6.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.891 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -101.0 -27.84 13.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -82.84 -176.24 6.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.441 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.14 130.81 38.66 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.601 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.77 138.37 31.63 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.282 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 57.2 mt -126.86 135.11 64.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -118.64 158.05 26.23 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.01 120.9 42.96 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -173.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 3.1 tpp180 -106.64 112.96 26.18 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.352 0.661 . . . . 0.0 110.183 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.96 158.66 23.81 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.818 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -66.79 -12.88 60.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.304 1.041 . . . . 0.0 110.437 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.0 -8.69 58.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.675 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.2 71.57 Favored Glycine 0 CA--C 1.506 -0.509 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.986 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.7 m -112.8 151.08 30.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -124.68 148.41 48.0 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.035 0.445 . . . . 0.0 110.888 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.67 141.34 22.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.642 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.75 147.45 11.41 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 124.139 0.9 . . . . 0.0 113.923 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.02 146.76 72.13 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.709 2.94 . . . . 0.0 114.243 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 24' ' ' ALA . 5.9 tmtm? -130.83 145.5 52.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -89.88 122.69 33.16 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.235 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 66.5 m-85 -120.12 126.36 26.87 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.97 149.07 90.7 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.262 1.975 . . . . 0.0 110.409 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.46 -28.5 68.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.757 0.313 . . . . 0.0 111.691 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.12 -2.61 57.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.6 m -72.12 130.42 40.84 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.665 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 25.3 p -79.4 156.28 28.0 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.159 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 88.0 t -62.4 -27.46 42.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.775 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 49.6 p -60.74 -46.48 90.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.37 -28.04 63.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.343 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 62.7 tp -63.5 -49.32 74.01 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 39' ' ' ILE . 95.5 mttt -63.05 -42.86 99.82 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' SER . 24.8 mm-40 -56.83 -38.16 72.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.647 0.261 . . . . 0.0 110.912 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.2 m -66.04 -43.07 88.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 62.6 t -62.54 -48.32 88.77 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.218 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 35' ' ' LYS . 58.0 mt -60.29 -33.02 52.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 m -72.36 -39.03 68.38 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 122.058 -0.401 . . . . 0.0 111.196 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.04 -26.85 39.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 120.948 0.404 . . . . 0.0 111.436 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -81.35 129.01 68.16 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 29.4 Cg_exo -57.84 124.67 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.98 1.787 . . . . 0.0 111.906 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -65.11 -31.61 72.9 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -86.11 3.52 42.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.095 -0.957 . . . . 0.0 113.177 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' PRO . 58.0 tptt -64.04 109.58 1.86 Allowed 'General case' 0 C--O 1.248 1.004 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.98 131.85 40.96 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' OD1' ' HB1' ' A' ' 94' ' ' ALA . 57.7 t30 51.97 84.23 0.05 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.186 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.47 23.14 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.346 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -66.76 51.38 0.35 Allowed 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 125.276 3.984 . . . . 0.0 112.972 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.9 -33.71 76.32 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.663 0.785 . . . . 0.0 112.611 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -131.0 172.02 12.55 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.23 -39.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.898 1.679 . . . . 0.0 114.031 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.45 -26.35 51.42 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.626 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 95' ' ' PRO . 15.2 mm-40 -87.02 -25.25 24.32 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.913 0.387 . . . . 0.0 111.698 -172.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 38' ' ' VAL . 7.6 p -94.18 117.89 38.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.616 0.722 . . . . 0.0 109.999 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.05 127.86 54.16 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.124 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.94 135.34 44.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.92 120.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 124.49 1.116 . . . . 0.0 110.898 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.415 ' HB3' ' SD ' ' A' ' 88' ' ' MET . 84.3 p -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.12 10.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.377 0.671 . . . . 0.0 111.884 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.31 -1.84 57.51 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.869 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -105.44 125.55 51.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.86 117.36 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB3' HG11 ' A' ' 31' ' ' VAL . 3.3 mm? -59.85 128.71 38.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.248 0.546 . . . . 0.0 112.102 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.02 32.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 10.2 p30 -58.63 -29.13 66.28 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.8 m -90.3 5.53 46.84 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.669 -0.812 . . . . 0.0 113.106 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -100.77 165.65 11.26 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 122.142 -0.349 . . . . 0.0 111.617 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 82.1 p -99.64 172.36 7.33 Favored 'General case' 0 N--CA 1.422 -1.839 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.7 -38.61 82.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.23 -32.27 68.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.674 1.19 . . . . 0.0 111.881 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.14 -26.56 67.77 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.928 -0.482 . . . . 0.0 112.276 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.79 -10.95 14.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.112 0.482 . . . . 0.0 111.082 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -125.01 175.57 7.25 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-O 121.557 0.694 . . . . 0.0 112.8 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 m -114.68 150.42 43.95 Favored Pre-proline 0 N--CA 1.409 -2.487 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.98 133.89 49.98 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.27 1.98 . . . . 0.0 110.312 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p -77.18 -37.56 26.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.322 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 m 55.79 21.68 4.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.945 1.298 . . . . 0.0 112.675 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -147.57 -162.91 1.65 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.6 166.63 16.76 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.93 87.47 2.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 121.511 0.672 . . . . 0.0 112.031 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.31 -10.53 27.39 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.33 118.66 21.45 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.73 132.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.225 0.536 . . . . 0.0 109.571 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.3 m -85.91 127.12 34.53 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m -96.73 117.55 31.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 60' ' ' SER . 52.3 tpp -103.26 136.47 42.97 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -95.26 126.97 40.94 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.503 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 128.67 62.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.18 115.85 39.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.993 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 50' ' ' PRO . 50.8 mm -89.3 101.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.424 -177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -126.82 111.49 14.26 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.364 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . . . -82.36 147.18 55.92 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.812 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 94' ' ' ALA . 23.1 Cg_exo -65.51 -175.16 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.283 2.655 . . . . 0.0 112.115 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.31 113.66 13.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.48 0.657 . . . . 0.0 111.818 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.0 m -150.95 102.85 3.01 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.13 -58.86 1.88 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -152.56 30.95 0.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.692 1.234 . . . . 0.0 108.207 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.54 92.91 2.42 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.68 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -178.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 138.33 49.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.934 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.52 144.72 1.51 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -88.99 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -85.03 74.9 10.45 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -98.75 -35.85 10.02 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 26' ' ' PRO . 72.9 mm-40 -109.25 -167.93 1.27 Allowed 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.145 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -104.98 138.16 41.62 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 14.6 mp0 -89.72 132.06 35.38 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.639 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 55.3 mt -122.65 137.44 56.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.014 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 65.0 pttt -122.48 156.66 33.63 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -105.65 120.08 40.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -110.63 119.56 39.54 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 90' ' ' VAL . 3.5 mm? -65.46 168.36 7.4 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.734 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 t -61.26 -33.48 73.59 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.339 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -82.94 -3.61 57.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.658 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.63 3.16 61.18 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.127 -0.558 . . . . 0.0 114.407 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.7 m -84.44 137.64 33.26 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.68 152.62 37.99 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 62.8 mt -105.43 140.59 22.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.29 135.82 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.364 1.04 . . . . 0.0 114.953 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.35 147.15 58.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 124.063 3.175 . . . . 0.0 114.537 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 11.0 mptt -129.51 164.42 23.79 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.16 123.67 33.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 36.8 m-85 -119.93 120.82 30.08 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 31.6 Cg_exo -60.83 149.66 87.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.146 1.897 . . . . 0.0 112.045 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.35 -22.37 66.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.314 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.64 51.42 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.138 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 71' ' ' VAL . 79.6 m -79.35 137.64 37.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.736 0.303 . . . . 0.0 110.337 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 68.5 p -87.15 164.04 16.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 120.835 0.35 . . . . 0.0 111.635 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 67' ' ' ASN . 89.4 t -66.11 -26.4 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 31.2 m -63.36 -49.37 74.12 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.349 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.2 61.96 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.417 0.627 . . . . 0.0 111.211 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 69.8 tp -63.4 -42.67 98.79 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 39' ' ' ILE . 98.7 mttt -72.01 -35.16 69.34 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.56 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 32' ' ' SER . 17.8 mm-40 -56.81 -37.45 71.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.194 0.521 . . . . 0.0 109.688 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -64.97 -43.87 91.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.924 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -51.8 68.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 53' ' ' VAL . 62.9 mt -57.6 -32.54 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.219 -178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.2 m -69.87 -39.17 76.48 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.99 -24.84 14.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CZ2' ' HD2' ' A' ' 50' ' ' PRO . 48.1 t-105 -77.87 137.06 62.12 Favored Pre-proline 0 C--N 1.287 -2.109 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.12 110.58 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.145 1.897 . . . . 0.0 110.802 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -70.21 -22.95 62.87 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.271 0.558 . . . . 0.0 110.904 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.72 -21.05 61.82 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.081 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.21 108.38 0.68 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -83.76 158.13 21.86 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.172 176.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER 69.67 10.81 7.74 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.738 0.78 . . . . 0.0 111.144 -177.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.99 -176.19 22.09 Favored Glycine 0 N--CA 1.406 -3.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 42' ' ' TRP . 50.6 Cg_exo -60.19 155.31 46.37 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.741 2.961 . . . . 0.0 113.367 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 41.5 mttp -149.7 -53.74 0.16 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.0 p -118.89 173.14 7.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.747 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 39' ' ' ILE . 27.3 m -53.16 -28.97 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 113.852 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.74 -27.43 65.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.548 0.69 . . . . 0.0 109.939 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 27.7 mt-10 -100.38 7.3 44.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.807 -169.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' PRO . 48.6 t -121.36 121.2 64.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -115.17 122.4 45.94 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 59' ' ' ILE . 2.6 mm? -102.03 123.47 45.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.642 0.258 . . . . 0.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 58' ' ' LEU . 1.8 mp -117.77 134.17 62.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.681 0.793 . . . . 0.0 109.723 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -123.48 115.05 20.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.65 20.61 10.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.884 0.874 . . . . 0.0 112.836 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.41 18.31 28.79 Favored Glycine 0 C--N 1.312 -0.751 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.178 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.03 133.29 49.1 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.32 135.86 24.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.56 121.82 24.42 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.377 0.608 . . . . 0.0 111.154 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -76.72 126.03 30.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 45.7 m-80 -57.21 -35.56 69.79 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.9 m -76.04 -12.18 60.08 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . 31.7 mmtp -90.36 166.11 13.48 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.97 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 3.4 m -113.77 165.8 12.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 29' ' ' THR . 98.4 t -59.6 -31.4 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.655 0.74 . . . . 0.0 109.935 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.69 -34.72 39.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.512 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -76.06 -20.76 57.47 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -107.23 -20.96 13.12 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.34 133.09 50.64 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.357 0.598 . . . . 0.0 111.418 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -75.17 165.95 49.53 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.81 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.33 155.05 1.28 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.467 2.778 . . . . 0.0 112.962 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.74 81.83 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.506 1.146 . . . . 0.0 111.336 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.2 t -101.53 139.74 36.77 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.545 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -76.25 99.62 4.81 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.853 0.835 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.0 -178.6 5.74 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.9 30.11 1.92 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.16 0.505 . . . . 0.0 110.346 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.33 78.45 0.86 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.06 133.22 47.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.421 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.11 134.62 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.522 ' HB ' HG12 ' A' ' 10' ' ' ILE . 21.8 m -83.93 126.89 33.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -113.69 118.1 33.38 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.284 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.01 123.27 39.55 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -86.93 123.77 32.4 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 14' ' ' LEU . 14.6 p -101.89 130.9 50.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-O 122.265 1.031 . . . . 0.0 111.744 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.2 mm -106.18 124.92 61.79 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 CA-C-N 113.759 -1.564 . . . . 0.0 107.971 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.21 107.86 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.792 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 99.0 mt-30 -136.54 110.52 8.25 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.988 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.12 158.69 32.34 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -36.11 146.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.743 2.962 . . . . 0.0 113.623 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.11 -50.89 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.041 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -102.19 95.29 6.22 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.136 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -118.18 108.99 15.84 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.53 78.79 1.55 Allowed 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -131.08 4.42 4.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.174 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.107 . . . . . . . . 2 2 . 1 stop_ save_